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Abstract 
Humans are exposed to low and moderate doses of ionising radiation (IR) from a 
range of diagnostic and occupational sources which may lead to cellular effects 
including genomic damage, cellular senescence and cell death. Cellular 
senescence is interesting because it is a normal, metabolically active form of 
tumour-suppressive growth arrest initiated in response to intrinsic and extrinsic 
stressors helping to prevent the proliferation of ageing/damaged cells.  However, 
in addition to this tumour-suppressive mechanism, senescent cells and tissues 
have also been linked with the development of a pro-oncogenic environment 
resulting from the secretion of an inflammatory phenotype. Indeed, senescence is 
thought to be important in a number of age-related pathologies and may influence 
the biological effects of radiation exposure. To assess the relationship between IR 
and stress-induced senescence we exposed mid and late passage primary normal 
human bronchial epithelial (NHBE) cells to low-LET Cobalt
60
 γ-rays (0-2 Gy) 
and fixed cells 0 min – 792 hours after exposure. DNA damage in both 
proliferating and senescent NHBE cells was quantified in nuclei co-stained for 
53BP1 DNA damage foci (average foci/nucleus and foci size), and Ki-67 
proliferation antigen, utilising manual and automated foci (AutoRIF) scoring 
methods.  As expected, 53BP1 foci were significantly induced in mid (5.3 and 
6.48 53BP1 foci/nucleus) and late (6.86 and 8.21 foci/nucleus) passage NHBE 
cells 30 minutes after exposure to 0.3 and 0.5 Gy respectively compared to sham 
(mid; 1.1 and late; 2.44 foci/nucleus); the elevated numbers of foci in the late 
passage cells reflect the increased background.  By contrast, cells that were 
cultured beyond this time did not reveal any elevations in foci number and instead 
a decline was observed at extended times.  This may result from cells with 
persistent DNA damage being removed from the population by apoptosis.  
AutoRIF analysis also determined that the proportion of medium and large foci in 
late passage NHBE cells was increased compared to mid passage nuclei, however 
no IR-induced increase in foci size was seen at late times after exposure.  
Additionally, approximately 30% of mid-passage NHBE cells were senescent (Ki-
67 negative) compared to 64% in late-passage cells, the fractions of which were 
also not influenced by our single dose exposures. 
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In conclusion, our preliminary experiments do not show any IR-modifying effects 
after the single acute doses examined, however the end-points studied and the 
base-line data generated offer an excellent platform from which to assess the long-
term cellular effects of exposure to acute and fractionated exposures of IR in 
primary NHBE cells. 
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1 Introduction 
1.1 Ionising Radiation 
Ionising radiation (IR) is energy that is released from atoms in the form of 
electromagnetic waves, such as x-rays, gamma rays (γ-rays) or as particles, such 
as alpha (α), beta (β) and neutron particles and which are of sufficient energy 
(~>10 electron volts (eV))  to result in the ionisation of an atom or molecule. Such 
ionisation events are capable of inducing biologically relevant damage including 
the formation of DNA double strand breaks (DSB) which may result in modifying 
cellular effects. Other electromagnetic waves including UV-A, UV-B, visible light 
and microwaves are not energetic enough to detach electrons from atoms and are 
therefore non-ionising.  Different types of IR show different patterns of energy 
deposition in the form of radiation track structures (Nikjoo et al. 1997) and these 
track structures will determine the spatial deposition of ionisation events and 
potentially the complexity of damage induced.  For example 1 Gray (Gy) of low 
linear energy transfer (LET; defined as the amount of energy deposited per unit 
distance) γ-rays corresponds to approximately 1000 electron tracks within a 
nucleus which on average results in the induction of ~40 double strand breaks 
(DSB) per cell, of which ~30% can be categorized as complex DSB.  Complex 
DSB are defined as lesions that include two or more individual lesions within one 
or two turns of helical DNA (Nikjoo et al. 1997, Brenner, Ward 1992) and are 
difficult to repair (Asaithamby, Chen 2011).  Compare this to 1 Gy of high LET 
α-particles that corresponds to ~2 alpha tracks and 40 DSB, of which 70% are 
complex (Nikjoo et al. 1998, Anderson et al. 2000) and it is clear to see the 
differences between induction and repair of damage between differing radiation 
qualities (Figure 1.1).  Thus, in addition to radiation dose, radiation of varying 
LET will induce a varying spectrum of damage at the molecular, cellular, tissue 
and organismal levels. 
The Sievert (Sv) is a unit that takes the differing relative biological effectiveness 
(RBE) of different types of IR into account and provides an equivalent radiation 
dose absorbed by the tissue.  The equivalent dose is calculated by multiplying a 
weighting factor (WR) by the absorbed dose in Gy, and this weighting factor takes 
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into account radiation type and energy (ICRP. 2007).  For example, α-particles 
have a WR of 20 which equates to a 1 Gy absorbed dose providing an equivalent 
dose in tissues of 20Sv, compared to γ-rays which have a WR of 1 whereby the 
equivalent dose (Sv) is equal to the absorbed dose (Gy) (figure 1.1). 
 
Figure 1.1 Schematic of a transverse section of a peripheral blood lymphocyte 
(PBL) cell nucleus crossed with high and low LET radiation.  Individual chromosome 
domains are shown in colour, being crossed by an α-particle (A) and electron tracks from 
two x-ray interactions (B).  Courtesy of Anderson RM, Stevens DL and Goodhead DT, 
2002 (Anderson, Stevens & Goodhead 2002).  
1.1.1 Sources and health effects of ionising radiation  
As a population we are continually being exposed to IR from a range sources 
including the natural radioactive gas, Radon and cosmic and γ-rays.  Other 
sources include radionuclides that are present within the soil, water and air that 
may be ingested with our food and water.  According to the Health Protection 
Agency (HPA) the average annual exposure to IR in the UK is 2.7 mSv which is 
mainly made up of background radon exposure from our homes (~1.3 mSv per 
annum/7.8 mSv in Cornwall per annum), as well as from use of diagnostic 
procedures such as x-rays (dental = 0.005 mSv, chest = 0.02 mSv) and computed 
tomography (CT) scans (head = 1.4 mSv, chest = 6.6 mSv, whole body = 10 
mSv).  It is easy to see how an increase in the use of x-rays and CT scans for 
diagnostic purposes could quickly increase the annual exposure (Hall, Brenner 
2008, Hall, Brenner 2008, Brenner et al. 2000).  The average annual occupational 
exposure received by nuclear power station workers is 0.18 mSv with an annual 
exposure limit of 20 mSv, which is well above the population average (Health 
Protection Agency 2012).  Other sources include acute accidental exposures to 
A B 
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ionising radiation such as those as a result of the explosions at the Fukishima 
nuclear plant (March 2011), as well as Chernobyl (1986) and Hiroshima (1945). 
It has been known for many decades that human exposure to high levels of 
radiation can cause acute radiation poisoning, cancer and even death.  The earliest 
known radiation-induced cancers were documented in Uranium miners in 1493-
1541 in Saxony and a causal link between high dose and low dose residential 
exposures and lung cancer was made at the beginning of the 20
th
 century 
(Schuttman 1993, Tirmarche et al. 1993, Darby et al. 2005, Darby et al. 2006, 
Krewski et al. 2006).  In striking contrast to a link between domestic radon 
exposure and lung cancer that has been well documented, evidence of a hormesis 
effect after low dose IR exposure forms the basis of Radon spa treatments that are 
still used today to treat a variety of ailments (Franke et al. 2000, Gastein’s 
Mountain – Helistollen, 2012).  
 The lethal dose of radiation that is expected to cause death in 50 percent of 
exposed individuals (LD50) is ~ 4 Gy (UNSCEAR. 2000) while partial-body or 
lower dose exposure (<1-2 Gy) will result in acute radiation effects or the 
promotion of cancers (Asaithamby, Chen 2009).  The HPA determine 100 mSv to 
be the level at which changes in blood cells can be readily observed, although as 
discussed later, maximum adaptive protection responses have been shown after 
single tissue doses of 100-200mSv and are absent at higher doses (Feinendegen, 
Pollycove & Neumann 2009).  The effects of exposures to moderate and high 
levels of ionising radiation are therefore relatively well understood, however the 
risks or benefits of low (<100 mGy/100mSv of whole body low LET) dose 
exposures are less understood.  As a result of this there is continuing controversy 
surrounding the shape of the dose-response curve for cancer risk, which according 
to the current Linear-no-threshold (LNT) extrapolation models are based on the 
paradigm that cellular effects are due to the direct damaging effects of radiation 
on DNA (figure 1.2; I).  Increasingly, the importance of non-targeted effects 
(NTE) (1.1.3) for example, genomic instability, bystander effects, the phenomena 
of persisting inflammation and adaptive/hormesis responses, may be of 
importance after low dose exposures (UNSCEAR. 2006).  Indeed non-cancer 
diseases including cardiovascular disease have been well documented in Atomic 
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bomb survivors (Yamada et al. 2004b) and as a result the relevance of NTE, 
especially after low dose exposures are becoming increasingly studied for 
radiation protection. Interestingly, these effects may increase the complexity of 
radiation responses and potentially give rise to outcomes that were not previously 
predictable using standard (LNT) models of cancer risk (HLEG Report. 2009). 
1.1.2 The linear no-threshold (LNT) hypothesis  
Current radioprotection is based on the LNT model of cancer risk which describes 
that there is no dose-threshold for excess risk and that dose is directly proportional 
to risk at low doses (Pearce et al. 2012).  This model suggests that cellular targets 
must be ‘hit’ in order to cause damage, however this has been shown to be 
contradictory at low doses with some experimental and epidemiological findings 
suggesting the model may be overestimating or underestimating the risks (ICRP. 
2007, UNSCEAR. 2000, Tubiana 2005, NRC (National Research Council). 2006).  
Of potential importance at low doses are the roles that radiation-related bystander 
effects, genomic instability and adaptive responses, play in cancer-associated 
risks.  Figure 1.2 highlights the contradicting potential risk responses to low dose 
exposures below 100 mGy. 
 
Figure 1.2 Low dose risk extrapolation:  Current models for low dose responses 
(HLEG Report. 2009). I) Linear-no-threshold (LNT); II) Upwardly curving with no 
threshold; III) Linear or upwardly curving but with a zero-effect interval below a given 
threshold dose; VI) Bi-modal relationships (beneficial hormesis/adaptive responses); V) 
Supra-linearity (hypersensitivity at low doses). 
V 
IV 
III 
I 
II 
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1.1.3 Non-targeted effects (NTE) 
Non-targeted effects (NTE) or radiation-induced bystander effects (RIBE) 
describe a whole range of cellular effects that are observed in un-irradiated cells 
upon communication with irradiated cells.  Collectively these factors are known to 
dominate at low radiation doses, are seen to saturate with increasing dose and 
mediate a range of cellular effects such as DNA damage (Azzam, de Toledo & 
Little 2001, Little J et al. 2003), cell death (Lyng F, Seymour C & Mothersill C. 
2002), cell proliferation, adaptive protective effects and malignant transformation 
(Nagasawa 1992, Mothersill, Seymour 1997, Lorimore et al. 1998, Sawant et al. 
2001, Dickey et al. 2009, Belyakov et al. 2005).  Many of the experimental 
systems describing these bystander phenomena have utilised the targeted 
properties of low fluence high-linear energy transfer (LET) α-particles enabling 
known fractions (Little et al. 1997), or known compartments (Wu, Pandolfi 2001, 
Wu et al. 1999) of cells to be intersected by α-particle tracks.  For instance 
Nagasawa and Little (1992) observed elevated sister chromatid exchanges (SCE) 
in ~30% of cells after direct exposure of less than 1% of the cell population 
(Nagasawa, Little 1992), while Wu et al (1999) showed an increase in 
spontaneous mutation frequency after cytoplasmic traversal of defined numbers of 
α-particles, demonstrating that the target for NTE is greater than the cell nucleus 
(Wu et al. 1999).  NTE have also been observed after exposure to low-LET 
radiations (Law, Wong & Yu 2010).  Mothersill and Seymour (1997) found that 
medium transferred from epithelial cells previously irradiated with low LET γ-
rays reduced the clonogenic survival of un-irradiated cells of the same type 
(Mothersill, Seymour 1997). The authors subsequently utilised this medium 
transfer model to show that cell-cell contact was not a requirement for NTE but 
that factors released into the extracellular medium after radiation exposure, 
mediated the effect (Mothersill, Seymour 1997, Mothersill, Seymour 1998, 
Seymour, Mothersill 2000, Sokolov 2005, Hamada et al. 2007).  Contrastingly, 
adaptive effects have been shown in peripheral blood lymphocytes (PBL), 
whereby the frequency of chromosome aberrations (CA) was reduced in cells 
exposed to a priming dose of 3H-Thymidine 48 hours before exposure to 1.5 Gy 
x-rays, and accordingly after an adaptive dose of 0.1 Gy followed by a 2 Gy 
challenging dose (Olivieri, Bodycote & Wolff 1984).  To date, this bystander 
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phenomena has also been observed in cells cultured in non-irradiated tumour or 
senescent cell conditioned medium (Dickey et al. 2009, Coppe et al. 2008), 
microbeam-irradiated human tissue (Belyakov et al. 2005, Sedelnikova et al. 
2007) and in vivo animal models (Coates, Lorimore & Wright 2004, Coates et al. 
2008, Ilnytskyy, Koturbash & Kovalchuk 2009).  Candidate sources for the 
mediation of NTE include activated macrophage, nitric oxide (NO), interleukin 6 
(IL-6), interleukin 8 (IL-8), interferon-gamma (IFN-γ) and transforming growth 
factor-beta (TGF-β) (Coates, Lorimore & Wright 2004, Coates et al. 2008, 
Dieriks et al. 2010), implicating that there are multiple complex mechanisms 
involved in the transmission of NTE including oxidative stress and inflammation, 
whereby inflammation-associated cytokines and chemokines are secreted from 
irradiated (or otherwise stressed) cells.  
1.2 Cellular effects of ionising radiation 
1.2.1 The DNA double strand break 
Exposure to IR results in a wide spectrum of damage including base damage and 
single strand breaks, however the most dangerous and critical form of DNA 
damage is the DSB (Burma et al. 2001, Anderson, Henderson & Adachi 2001).  
Endogenous and exogenous damage alone typically produces approximately 
50,000 lesions per cell per day, and therefore cells have developed complex 
response mechanisms involving over 100 genes that are involved in the response 
and repair of this cellular damage.   
Formation of a DSB is initially sensed by the Mre11-Rad50-Nbs1 (MRN) 
complex which results in Nijmegen breakage syndrome 1 subunit (NBS1) 
recruiting the initiating phosphoinositide (PI)-3/4-kinase Ataxia telangiectasia 
mutated (ATM) bringing it to the site of the DSB.  ATM undergoes rapid 
autophosphorylation which triggers phosphorylation of histone H2AX at serine 
139 (γ-H2AX) and the binding of the mediator protein MDC1.  This interacts with 
the MRN complex and tethers it to the site of the DSB within 1-3 minutes (Lee, 
Paull 2005, Rogakou et al. 1998).  Further ubiquitinylation and methylation of 
H2A histones in the vicinity of the DSB results in chromatin modifications that 
allow access of DNA repair proteins such as tumour suppressor p53 binding 
protein 1 (53BP1) and breast cancer type 1 susceptibility protein (BRCA1) to the 
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site, where they form large nuclear domains known as foci (Maser et al. 1997, 
Rogakou et al. 1999, Mailand et al. 2007, Mailand et al. 2007).    53BP1 protein 
is thought to be a conserved checkpoint protein that also acts as an early sensor of 
DNA DSBs (Anderson, Henderson & Adachi 2001, Schultz et al. 2000b, Rappold 
et al. 2001, Mochan et al. 2003).  The protein consists of 1972 amino acids, a 
tudor domain and 2 tandem BRCT domains (Iwabuchi et al. 1998) and its gene is 
located on chromosome 15.  53BP1 identifies with the central binding protein of 
tumour suppressor p53 and as a result becomes hyperphosphorylated in response 
to radiation and co-localizes with phosphorylated H2AX at sites of DSB (Ward et 
al. 2003).  As well as being dependent on γ-H2AX, localization of 53BP1 has also 
been shown to be dependent on MDC1 and changes in higher-order chromatin 
structure (Bekker-Jensen et al. 2005, Xie et al. 2007, Huyen et al. 2004).  53BP1 
foci were seen to form independently of ATM at DSB sites after irradiation 
(Schultz et al. 2000a) localizing in discreet nuclear foci at the sites of DSBs 
within 5-15 minutes in response to IR, peaking at 30 minutes and then declining 
in number thereafter as a result of cellular repair mechanisms (Schultz et al. 
2000b).  
The sensing of DSB also leads to the phosphorylation of checkpoint proteins 
CHK1 and CHK2 results in phosphorylation of the tumour suppressor p53, and 
via up-regulation of the cyclin dependant kinase (cdk) inhibitor p21, p53 inhibits 
the action of cdk2-kinase activity causing the cell cycle to be arrested in G1 
(Abraham 2002).  This allows time for initiation of non-homologous end-joining 
(NHEJ) or homologous recombination (HR) repair to occur; however if a cell fails 
to correctly repair DNA damage, apoptosis may be initiated in order to prevent the 
continuation of mutations and chromosome rearrangements (Paull et al. 2000, 
Shimada, Nakanishi 2006).  Alternatively cells may enter a permanent state of 
arrest known as cellular senescence. 
1.3 Cellular Senescence 
Cellular senescence is a metabolically active form of irreversible growth arrest 
that halts the proliferation of ageing and/or damaged cells and as a consequence, 
prevents the transmission of damage to daughter cells.  It is essentially a 
protective mechanism to prevent neoplastic transformation in cells that may have 
accumulated unrepaired DNA damage and replication errors as a result of 
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increasing replication cycles or as a result of the exhaustion of a cell’s determined 
replication capacity.  This occurs when normal diploid cells lose their ability for 
cell division, which irreversibly arrests cellular proliferation.  This complicated 
cellular event is initiated in response to a variety of stimuli (Campisi 2001, 
Wright, Shay 2001, Ben-Porath, Weinberg 2005) including intrinsic factors, 
oncogenic damage and intrinsic/extrinsic genotoxic stressors (Davalos et al. 
2010).  It is mediated by tumour suppressor pathways involving p53, and 
p16INK
4a
/pRb (Kulju, Lehman 1995, Narita et al. 2003) that lead to the inhibition 
of cyclin-dependant kinases (Mehta et al. 2007, Blagosklonny 2003).  
Accordingly, cellular senescence can be thought of as a tumour suppressor 
mechanism.  Indeed the majority of cancers have mutations in p53 and/or the 
pRb/p16 pathways, while germ-line mutations in these pathways result in a cell-
specific ability to overcome senescence-inducing signals, greatly increasing 
susceptibility to cellular transformation (Ohtani et al. 2004, Gil, Peters 2006, 
Collins, Sedivy 2003).  The importance of senescence as a tumour suppressor 
mechanism is further demonstrated by evidence that shows senescent cells to have 
a strong influence over the growth of proliferating cells and cellular oncogenes of 
tumour cells (Smith, Pereira-Smith 1996).  For instance, when proliferating cells 
were fused with senescent cells, DNA replication was inhibited even in the 
presence of mitogens, and when senescent cells were fused with tumour cells, 
DNA replication was similarly inhibited (Yanishevsky, Stein 1980).  These 
findings led to the assumption that senescent cells contained control elements 
capable of exerting a dominant effect over proliferating pre-senescent cells.  
Importantly, this tumour suppressive mechanism of cellular senescence has been 
supported in both mice and human studies (Serrano, Collado 2010).  Senescence 
has also been shown to play an important role in wound healing and tissue repair 
and/or communication to surrounding tissues/cells of damage crisis to assist 
healing (Coppe et al. 2008, Coppé et al. 2010).  For example, senescent cells have 
been shown in in vivo mouse models to play a role in the resolution of fibrosis 
through the action of matrix metalloproteinases (MMPs) after acute liver injury.  
Under normal conditions, proliferating hepatic stellate cells, triggered in response 
to acute liver injury, produce fibrotic scars in advance of entering into a senescent 
state and secretion of MMPs results in dissolution of the scars.  However in cells 
deficient in either p53/pRb pathways, liver injury results in severe, irresolvable 
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fibrosis (Krizhanovsky et al. 2008).  Similarly, the matricellular protein CCN1, 
which is expressed at sites of cutaneous wound repair, has been shown to initiate 
DNA damage response pathways and reactive-oxygen species-dependent 
activation of p16INK4A/pRb pathway, resulting in fibroblast senescence and the 
expression of anti-fibrotic genes in wild-type mice. Mutant mice that express a 
senescence-defective CCN1 protein show increased fibrosis at sites of wound 
repair (Jun, Lau 2010).  Another primarily beneficial function of senescence is the 
prevention of epithelial-mesenchymal transition (EMT) and thus prevention of 
metastatic dissemination of cancerous cells (Evan, d’Adda di Fagagna 2009, 
Birchmeier, Birchmeier 1995) 
 Senescent cells may also have an impact on neighbouring non-senescent cells, 
and tissue function and integrity in ageing, (Stein et al. 1999).  Senescent 
fibroblasts cause an inflammatory response through release of cytokines and 
metalloproteinases that break down the collagen matrix secreted by normal 
fibroblasts, a mechanism which may contribute further to the ageing of tissues 
(Bassi, Sacco 2009). 
The major phenotype of senescence that characteristically distinguishes 
senescence from quiescence is irreversible growth arrest associated with 
resistance to apoptosis and increased sensitivity to cellular injury (Wang 1995, 
Campisi 2000, Ryu, Oh & Park 2007, Rochette, Brash 2008, Chaturvedi et al. 
2004, Hampel et al. 2004, Labinskyy et al. 2006).  Other characteristic alterations 
of senescence include but are not exclusive to, altered gene expression with 
increased expression of proteins including p53, p16, p19 and p21 (Shelton et al. 
1999, Kristnamurthy 2006), an increase in senescence-associated beta 
galactosidase (SA-β-gal) activity at pH 6.0 (Dimri 1995) the presence of persistent 
telomere and non-telomere DNA damage foci (Herbig et al. 2004, Bakkenist et al. 
2004, Sedelnikova 2004), senescence-associated heterochromatic foci (SAHF) 
(Narita et al. 2003, Kosar et al. 2011) and a senescence-associated secretory 
phenotype (SASP) (Campisi 2005, Kuilman, Peeper 2009).  Cellular stains that 
can be used in addition to SA-β gal include the proliferation cell-cycle specific 
marker Ki-67 (Bridger, Kill & Lichter 1998, Gerdes et al. 1984, Gerdes 1990).  
Kill et al (1996) showed that human dermal fibroblasts (HDFs) were 56% Ki-67 
positive at early passage 4 (Kill 1996) compared to only 30% at passage 38 
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(Bridger et al. 2000), with the decrease in fraction of Ki-67 positive cells 
indicating an increasing fraction of senescent cells within culture.  
Morphological changes are also evident in the nuclear structures and nuclear 
morphology of senescent cells, with senescent fibroblasts showing an enlarged 
and flattened morphology that is accompanied by loss of elongated, spindle-like 
properties, when compared to normal proliferating fibroblasts.  Mean nuclear area 
was shown to be 255µm
2
 at early passage, compared to 293µm
2 
at later passage 
(Mehta et al. 2007).  Interestingly, the sub-nuclear organisation of chromosomes 
has also been shown to be different in senescent and proliferating mammalian 
somatic cells, whereby gene poor chromosomes such as 13 and 18 are thought to 
relocate from the nuclear periphery to the nuclear interior, with their radial 
positioning correlating to their size, instead of gene density (Bridger et al. 2000, 
Meaburn et al. 2007).    To date though, no unique biological marker has been 
found, and, consequently, the identification of senescent cells relies on assaying 
for a combination of the above characteristics. 
1.3.1 Stress-induced premature senescence (SIPS) 
In contrast to replicative senescence that occurs when a normal cells division 
capacity is exhausted, stress-induced senescence, also known as premature 
senescence, culture shock and STASIS (stress or aberrant signalling-induced 
senescence) (Chen 2004, Serrano 1997, Ramirez et al. 2001), also occurs rapidly 
in response to a variety of intrinsic or extrinsic stressors, including DNA damage 
from IR and non-IR radiation, cytotoxic DNA damaging agents, oxidative stress, 
as well as a consequence of oncogenic activation (oncogene-induced senescence) 
(Ben-Porath, Weinberg 2005, Davalos et al. 2010, Blagosklonny 2003, Serrano, 
Blasco 2001).  Serrano et al (1997) were among the first to identify a form of 
SIPS that was not attributable to telomere attrition that they described as 
oncogene-induced senescence (OIS).  The group showed that oncogenic ras 
expression permanently arrested primary human and rodent cells in G1, which was 
accompanied by an accumulation of p53 and p16 and evidence of phenotypic 
characteristics similar to cells in replicative senescence (Serrano 1997).  Further, 
expression of the catalytic subunit of the telomerase enzyme hTERT has been 
shown not to abrogate SIPS, demonstrating that cellular senescence can be 
triggered prematurely independently of telomere attrition.  Expression profiles of 
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p53, p21 and p16INK4A have also been shown to resemble those of replicatively 
senescent cells (Robles, Adami 1998, Wei, Wei & Sedivy 1999).  Thus, stressors 
that lead to DNA damage but which are independent of loss or dysfunction of 
telomeres, initiate a response that results in a cellular phenotype indistinct to that 
observed for replicative senescence (Pazolli, Stewart 2008, Zglinicki et al. 2005).  
 
Figure 1.3 Scheme highlighting initiating and molecular mediators of cellular 
senescence.  The senescent phenotype includes expression of SA-β-galactosidase (SA-β-
gal), increased expression of p16INK4a leading to cell cycle arrest and an increase in the 
secretion of pro inflammatory factors termed as senescence-associated secretory 
phenotype (SASP). Senescent cells have been observed in normal ageing cells and in 
cells/tissues of various age-related pathologies (Sabin, Anderson 2011).  See appendix for 
journal article. 
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1.3.2 The molecular pathways of senescence 
The initiating event for both replicative senescence and SIPS involves the 
recognition of DNA damage and activation of the DNA damage response (DDR) 
pathway (Ben-Porath, Weinberg 2005, Rodier et al. 2005, Ben-Porath, Weinberg 
2004, Nakamura et al. 2008, d’Adda di Fagagna et al. 2003, Kastan et al. 1992). 
Activation of the DNA damage response kinase ATM, a key mediator in the 
cellular response to ionising radiation, and γ-H2AX foci, have both been shown to 
increase in both murine and human senescent cells in vitro (Nakamura et al. 2008, 
d’Adda di Fagagna et al. 2003, Kastan et al. 1992). 
This activation results in downstream phosphorylation of p53 which leads to up-
regulation of the cyclin-dependant kinase inhibitor p21, resulting in inhibition of 
CDK2 kinase activity and cell cycle arrest in G1 (Abraham 2002).  Stress-induced 
cellular senescence is thought to depend upon the P16INK4 family of tumour 
suppressor proteins, activated upstream to pRb and described for its ability to 
arrest the cell cycle and induce cellular senescence (Gil, Peters 2006, Finkel, 
Serrano & Blasco 2007).  Accordingly, increased P16INK4a expression is another 
useful marker of senescence in vitro, and was detected in ageing baboon 
fibroblasts along with markers of telomere damage and SAHF (Jeyapalan et al. 
2007).  p21 also activates pRb through the inhibition of E/CDK2 (Campisi 2001).  
The hypophosphorylated state of pRb results in inhibition of the transcription 
factor gene E2F and this brings about G1 cell cycle arrest.  For this reason, the p53 
and p16/pRB dependent senescent pathways are not completely separable and as 
well as the common link through p21, pRB has been shown to regulate the 
activity of MDM2 which acts to control the stability of p53 (Yap et al. 1999).   
The p53 target of p21 is found to be increasingly expressed during replicative 
senescence, whilst playing a role in premature senescence in response to DNA 
damage, oxidative stress or oncogenic over-expression (Zhang 2006).  The DNA 
damage response, senescence and apoptotic pathways therefore share common 
lineages through p53 and p21. What directs a cell to senesce or apoptose remains 
unclear, but cell type, the type of damaging agent and the dose administered is 
thought to be important; as well as the post-translational modifications that p53 
undergoes (Webley et al. 2000).  What is clear is that the convergence of multiple 
pathways through p53 and pRb are required to maintain the senescent state and 
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removal of either of these has shown to prevent senescence in mouse embryonic 
fibroblasts (Dirac, Bernards 2003).  In humans, it is thought that both p53 and 
pRb pathways must be inactivated in order to prevent the onset of cellular 
senescence (Smogorzewska, de Lange 2002) and accordingly research suggests 
that 50% of tumours show evidence of mutated/non-functional p53 highlighting 
its importance in tumour suppression (Kaul et al. 2003, Shay, Pereira-Smith & 
Wright 1991).  p53 is also associated with apoptosis of cells that have obtained 
irreparable damage and it has been found that cells deficient in p53 are unable to 
arrest cell growth at G1 in response to γ-radiation, including a reduced ability to 
apoptose.  Interestingly though, senescence has been found to be triggered 
independently of Rb in humans (Ben-Porath, Weinberg 2005) with activation of 
p53 and pRb occurring through activation from p19ARF and p16INK4A products 
from the INK4A locus respectively, and suppression of mitogenic stimuli.   
1.3.3 Cellular senescence and age-related pathology 
Senescence has also been linked to reduced tissue functionality and is increasingly 
thought to play a role in age-related pathologies such as cancer, Alzheimer's, 
diabetes and obesity (Erusalimsky, Kurz 2005, Price et al. 2002).  Cancer is 
commonly defined as an age-related pathology with an increasing incidence of 
carcinomas reported in the older population, namely of the breast, colon, lung and 
prostate (Wu, Pandolfi 2001, DePinho 2000, Beghe, Balducci 2005, Artandi et al. 
2000).  Senescent cells have been observed in many ageing mice tissues (Wang 
1995, Wang et al. 2009) baboon skin fibroblasts (Jeyapalan et al. 2007) and 
human tissues (Dimri 1995) indicating that senescence may have a causal role in 
ageing in vivo as well as in vitro.  Senescent endothelial cells have been shown to 
increase in atherosclerosis, thrombosis and at sites of inflamed vascular 
endothelium (Evan, d’Adda di Fagagna 2009, Erusalimsky 2009, Erusalimsky 
2009) further to which, the accumulation of senescent haemopoietic stem cells has 
been suggested as a possible mediator for the decline in tissue regeneration and 
repair with age.  Indeed markers of DNA damage are known to accumulate in 
ageing stem cells (Chen 2004, Rossi et al. 2007, Nijnik et al. 2007, Janzen et al. 
2006).  Similarly γ-H2AX foci indicative of DSBs, were seen to accumulate in 
normal human fibroblasts, WI38 fibroblasts and PrEC prostate epithelial cells 
with increasing passage that correlated with an increasing fraction of SA-β gal 
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positive cells (Sedelnikova 2004).  Thus it can be suggested that there is a 
relationship between cellular ageing and the accumulation of residual DNA 
damage in vitro and in vivo, however there is no evidence yet to conclusively 
determine whether senescence is a resultant part of ageing and age-related 
pathologies or whether it is a state that contributes to the development of ageing 
tissues and tissue pathology. Interestingly, mouse models of accelerated ageing 
that are deficient for p16INK4a show delayed onset of age-related phenotypes, 
highlighting the role of increasing p16INK4a in maintaining the senescent state 
and its role in age-related decline of tissue regeneration and repair (Baker, Jin & 
van Deursen 2008).  Recently Baker and colleagues showed for the first time that 
cellular senescence is causally implicated in the generation of age-related 
phenotypes by the development of a transgenic mouse system that allowed for the 
inducible removal of p16INK4A positive cells upon administration of a drug that 
induces FK506-binding-protein-caspase8 activation.  Removal of these life-long 
senescent cells resulted in a delayed onset of age-related pathology of the adipose, 
skeletal and eye tissue, and although it did not result in an increased lifespan, an 
increased ‘health span’ was observed in the mice (Baker et al. 2011).  More 
studies are needed to determine what the effect would be on life-long removal of 
these cells as they are known to have beneficial effects as described above, 
however this is an important development that will hopefully decipher the 
evidential link between increasing populations of senescent cells/tissues and the 
contribution they have in the development of age-related pathologies such as 
cancer, through tissue damage and persistent inflammation (Sikora et al. 2011, 
Vijg, Campisi 2008). 
1.3.4 Senescence-associated secretory phenotype 
Senescent cells have been shown to secrete factors such as interleukins, 
chemokines, growth factors and proteases which encompass what is known as a 
senescence-associated secretory phenotype (SASP) (Coppé et al. 2010, Campisi 
2005, Freund et al. 2010).  SASP is thought to mediate growth arrest via the 
autocrine activities of pro-inflammatory cytokines (IL-6 and IL-8), as well as pro-
apoptotic protein insulin growth-factor binding protein 7 (IGFBP7), epithelial 
growth factors (heregulin and VEGF), matrix metalloproteinases including MMP-
3 and plasminogen activator inhibitor 1 (PAI-1) (Acosta et al. 2008, Wajapeyee et 
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al. 2008, Kortlever, Higgins & Bernards 2006).  Although SASP remains to be 
fully characterised, it is known to influence the proliferation of neighbouring cells 
and disrupt tissue architecture (Parrinello et al. 2005), principally through pro-
inflammatory influences.  For instance, an increase in VEGF has been seen in 
human and mouse fibroblasts, stimulating tumour vascularisation and invasion of 
basement membranes as a result of senescent fibroblasts stimulation (Coppé et al. 
2006).  Indeed the name ‘senescence-messaging secretome’ (SMS) was proposed 
to highlight that the associated factors of the secretory phenotype were not only 
essential for the maintenance of the senescent state, but that they also possessed 
communicative functions mediated by autocrine and paracrine signals (Kuilman et 
al. 2008, Kuilman et al. 2010).  A study to highlight this communication showed 
that re-activation of endogenous p53 in p53-deficient tumours in a mosaic mouse 
model of hepatocellular carcinoma led to tumour regression.  This was proposed 
to occur through the induction of cellular senescence and up-regulation of 
inflammatory cytokines, triggering an innate immune response in vivo that 
ultimately led to tumour clearance (Xue et al. 2007).  Thus, inflammatory 
cytokines are highlighted in the establishment and maintenance of senescence, 
suggesting an essential function of the SASP/SMS products in the suppression of 
malignancy (Acosta et al. 2008, Kuilman et al. 2008).  Several in vivo and in vitro 
studies have indicated that senescent cells can actually promote the progression of 
malignancy; a relationship that is described as antagonistically pleiotrophic 
(Campisi 2000, Coppé et al. 2006, Yeager et al. 1998, Reddel 2000, Campisi, 
d'Adda di Fagagna 2007, Campisi 2007).  For instance, senescent human 
fibroblasts have been shown to stimulate pre-malignant and malignant fibroblasts 
to hyperproliferate and form tumours in mouse models when senescent cells 
comprised ~10% of the fibroblast population (Krtolica et al. 2001).   Close 
proximity of senescent fibroblasts to pre-neoplastic cells are thought to be the 
trigger for this change.  Additionally, after exposure to the DNA-damaging agent 
bleomycin, human SIPS fibroblasts co-transplanted into xenografts of 
immunodeficient mice were also seen to stimulate nearby cancer cells to 
proliferate, either directly or through local tissue damage and inflammation 
mediated by MMPs (Liu, Hornsby 2007).  Inflammation is thought of as a key 
mediator in cancer development and inflammatory cytokines and MMPs are being 
increasingly implicated as a contributing factor in this multistep process.  
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Alteration of the tissue microenvironment and promotion of epithelial cell growth 
as a consequence of the senescent phenotype, through inflammation, persistent 
tissue damage, cellular proliferation, angiogenesis and cell motility (Davalos et al. 
2010, Coppé et al. 2010, Bassi, Sacco 2009) may thereby provide a mechanism 
that may contribute to cancer promoting effects in ageing tissues (Krtolica, 
Campisi 2002).  Models that assess the effects of senescent cells on nearby pre-
neoplastic or neoplastic cancer cells therefore support the theory that senescence 
is antagonistically pleiotrophic; being thought to protect young animals from 
cancer by mechanisms of tumour suppression, whilst contributing to deleterious 
effects in aged organisms through persistent inflammation and tissue injury 
(Bassi, Sacco 2009, Krtolica et al. 2001). 
 
1.3.5 Relationship between senescence and ionising radiation 
Ionising radiation has been shown to induce a SIPS phenotype instead of 
apoptosis in fibroblasts both in vitro and in vivo after exposure to high and low 
levels of damage, with cells showing a preference towards entering premature 
cellular senescence as a result of small levels of cellular damage (Suzuki et al. 
2001, Tsai et al. 2005, Tsai et al. 2009).  In normal cells with intact signalling 
pathways, senescence, in place of apoptosis has shown to be the more favourable 
route after low levels of DNA damage, perhaps as the cell makes the decision to 
attempt to repair instead of removing the cell (Ben-Porath, Weinberg 2005).  The 
status of the tumour suppressor phosphate and tensin homolog (PTEN) was shown 
to affect the cellular response of glioma cells with PTEN-deficient cells seen to 
enter senescence, and PTEN-proficient cells seen to enter apoptosis in response to 
ionising radiation exposure.  It was therefore determined in this instance that 
premature senescence was a compensatory mechanism in the place of apoptosis in 
the absence of the PTEN tumour suppressor (Lee et al. 2010).  By contrast, adult 
human dental pulp stem cells (DPSCs) were found to enter premature senescence 
in the G2 phase of the cell cycle after exposure to high doses (2-20 Gy) of ionising 
radiation, as detectable by SA-β-gal activity, phosphorylated p53 and increased 
p16 expression.  The increased p16 expression was observed for the experimental 
period of 13 days, coinciding with SA-β-gal activity at day 3 after irradiation, 
demonstrating the induction of a premature senescent state in response to ionising 
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radiation exposure and highlighting the complexities of damage response 
phenomena (Muthna et al. 2010).  It has been noted that some cell types have 
delayed onset of senescence upon inactivation of p16 only, whereas others require 
a deficiency in p53, or both in order to abrogate senescence,  This pathway 
abrogation in turn allows a cancer to develop more invasive features and undergo 
metastatic dissemination (Ansieau et al. 2008). 
In addition to this, immunological ageing or immunosenescence is known to result 
in decreased cellular proliferation, increased resistance to apoptosis and 
alterations in the T-cell balance (Spaulding, Guo & Effros 1999, De Martinis et al. 
2007, Giovannetti et al. 2008).   Interesting observations in human and animal 
studies show that a correlation exists between the immunological imbalances 
caused as a result of exposure to ionising radiation and, those effects which are 
seen in normal aged immune cells, implying ionising radiation may accelerate 
immunological ageing (Park, Jo 2011).  For instance, the normal age-related 
decrease of total CD4
+
 T-cells was found to be ~4% per 10 years, compared to a 
radiation-induced decrease of ~2% Gy
-1
, equivalent to a 5 year age increase per 1 
Gy (Kusunoki et al. 2010, Kusunoki et al. 1998).  This group also demonstrated a 
dose-dependent increase in CD25
+
/CD127
-
 regulatory T-cells and attributed T-cell 
immunosenescence to a higher level of inflammatory markers in Atomic bomb 
survivors.  For instance, changes in the immunological profiles of cytokines, 
known to be involved in the coordination of the inflammatory response (tumour 
necrosis factor –alpha (TNF-α), IFN-γ, IL-6 and IL-10), are seen in both Atomic 
bomb survivors and liquidators which may contribute to the persistent subclinical 
inflammatory status that is seen in these individuals (Hayashi et al. 2003, Hayashi 
et al. 2005, Kusunoki et al. 2003, Nakachi et al. 2004).   Therefore radiation-
induced enhancement of inflammatory reactions may contribute to the 
development of radiation-induced disorders and premature ageing (Kusunoki et 
al. 2010, Yamada et al. 2004a).  Indeed, it is also well known that Atomic bomb 
survivor’s show increased cardiovascular and respiratory diseases associated with 
persistent inflammation (Van der Meeren et al. 2008, Neriishi 2001, Lehnert, 
Goodwin 1997, Rubin et al. 1995, Yentrapalli et al. 2013).  The potential role of 
senescent cells in the mediation of NTE  (e.g. via SASP) as discussed in section 
1.3.4, the relevance of exposure to radiation in the initiation of SIPS, and the long 
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term tissue damage and pathological alterations that may arise as a consequence 
remain to be elucidated (Nagasawa 1992).  
1.3.6 The lungs as a target for Ionising Radiation exposure 
  
The biology of radiation-induced lung cancers is becoming of increasing 
importance and a causal link between domestic exposure to Radon gas and small 
cell lung carcinoma (SCLC) has been well documented (Darby et al., 2005).  The 
main target tissue for inhaled radon gas is the lungs and bronchioles and therefore 
this highlights the relevance of studying radiation effects in an important target 
organ. 
 
The normal human bronchial epithelium is composed of specialised epithelia cell 
types including ciliated columnar epithelium, mucous-secreting goblet cells (non-
ciliated secretory columnar cells) and the smaller more predominant basal cells, as 
well as the presence of immune and inflammatory cells that assist and aid 
epithelial cell function  (Knight, Holgate, 2003).    These basal cells are thought to 
be undifferentiated epithelial cells that make up the progenitor population of the 
cells and have the ability to differentiate into both ciliated and goblet cells in 
culture (Fig 3.1) (Vaughan et al. 2006).  Differentiation of these normal human 
bronchial epithelial cells (NHBE) by culturing at the air liquid interface (ALI) 
which effectively mimics a more in vivo environment (Danahay et al. 2002, 
Sedelnikova et al. 2007) results in the formation of ciliated-columnar epithelial 
cells and mucous-secreting goblet cells, which can be detected by β-tubulin IV 
and mucin respectively (Vaughan et al. 2006).  This technique is therefore widely 
used to allow better representation of an in vivo environment and represents and 
provides a focus for future work in this study. 
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1.4 Aims and objectives 
The aim of this project is to understand and assess the early and late effects of 
ionising radiation (IR) in primary human bronchial epithelial cell models after 
exposure to low-moderate doses.  Specifically we aim to determine IR effects on 
DNA damage and cellular senescence.  Beyond this, we aim to determine 
inflammatory responses, and whether initiation of a premature stress-induced 
cellular senescence phenotype may amplify radiation-induced effects at extended 
times after low dose exposures.  
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2 Materials and Methods 
2.1 Preparation of cell culture environment 
All cell culture work and preparation for experimental work was performed using 
aseptic techniques within the University cell culture suite using a Class II 
HeraSafe Laminar flow hood to maintain the sterility of cultures and of the 
equipment used.  All bio-hazardous waste including cell culture medium and 
equipment was decontaminated in Virkon disinfectant overnight prior disposal 
and autoclaving for sterility.  Disposal of all reagents was undertaken according to 
risk assessment and COSHH forms. 
2.2 Cell Culture 
Four different cell types were used; AGO1522 and 1HD (human dermal 
fibroblasts) and MCF-7 cells (human breast adenocarcinoma cell line) were used 
in method development, while primary human bronchial epithelial (NHBE) cells 
were the model cell type used for the majority of the experimental procedures.   
All 4 cell types grew as adherent cultures on plastic dishes/flasks (NUNC). 
2.2.1 Cell Types  
2.2.1.1 Primary Normal Human Bronchial Epithelial Cells (NHBE) 
Primary normal human bronchial epithelial (NHBE) cells were obtained from 
Lonza, Clonetics
®
 frozen in cryovials at passage (P) 1.  These NHBE cells are 
directly obtained from explants derived from areas of bronchial tissue distant from 
any pathology; these cells were assigned as P2 once they were reintroduced back 
into culture (2.2.2).  Frozen cells were thawed rapidly by warming the cryovials to 
37°C and diluted into an appropriate volume of specialized bronchial epithelial 
growth medium (BEGM) detailed in section 2.2.3.1.  The cells were passaged 
continually from this point in order to cryopreserve cells at each subsequent 
passage for future stocks until the population ceased to maintain normal 
exponential growth (~P11) or morphological changes suggested differentiation.  
In order to maintain viability and steady growth, NHBE cells were seeded at 
approximately 3500 cells/cm
2
 (2.62 x 10
5
 cells in a T75 flask) and were passaged 
once they reached no more than ~85% confluence.  This initial seeding density 
was increased as the cells reached later passages to ensure viability was 
maintained.  
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Details of the NHBE cell donors are shown in table 2.1, with Donor 2 being a 52 
year old Hispanic female, and Donor 3 a 43 year old Caucasian male.  All 
experimental work was carried out using donor 3 NHBE, unless otherwise stated 
in which case, donor 2 cells were used. 
According to the manufacturer’s guidelines, all primary cells from Lonza have 
been tested and are negative for HIV-1, mycoplasmas, Hepatitis B and C, bacteria, 
yeast and fungal infections 
Table 2.1 Lonza NHBE cell donor information  
Donor 
Lot No 
Age Sex Race Cell 
passage 
Cell 
count 
(cell/ml) 
Doubling 
time 
(hours) 
Total 
population 
doublings 
4F1624 
(Donor 
2) 
52 Female Hispanic 1 572500 19 18 
6F4180 
(Donor 
3) 
43 Male Caucasian 1 665000 25 15 
  
Figure 2.1 Phase contrast images of P4-P5 NHBE cell morphology in culture. 
Images acquired using JuLi Cell Analyser microscope (Montreal Biotech) with a 4x 
objective and 10x digital zoom.  A stage graticule was used to identify the pixel aspect 
ratio of 0.746 pixels/µm.  Scales bars represent 100µm (A) and 25µm (B). 
Three different cell types are present in the NHBE population; mucus secreting 
goblet cells, columnar epithelial cells and basal cells.  The normal morphology of 
these cells in culture show approximately 30% to be goblet cells and the 
predominating epithelial types to be basal and then columnar cells respectively. 
2.2.1.2 Human Dermal Fibroblasts 1HD/AGO1522 
The human dermal fibroblasts used in this study were initially derived from 
juvenile foreskin by Dr Bridger (1998), and termed 1HD (Bridger et al. 1998); or 
A B 
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normal human skin fibroblasts (AGO1522) were obtained from Coriell Cell 
Repositories. 
1HD/AGO1522 cells were thawed as described in section 2.2.2 to 37°C, before 
placement into 20mls of pre-warmed Dulbecco’s modified eagle medium 
(DMEM; 2.2.3.2) in a T75 culture flask.  Cells were maintained in 20mls of 
medium until cells were 85-90%  confluent and passaged as described (section 
2.2.5).  1HD/AGO1522 dermal fibroblasts were seeded at a density of 1-5 x 10
5
 
cells per T75 flask depending on the rate of growth required.  
  
Figure 2.2 Phase contrast images of P20 AGO1522 dermal fibroblasts.  
 Images taken with JuLi Cell Analyser. 
2.2.1.3 Human breast adenocarcinoma cell line MCF-7 
A cryovial of the human breast adenocarcinoma cell line, MCF-7 (P215) was 
kindly donated for use courtesy of Dr Mariann Rand-Weaver.  The MCF-7 cell 
line was originally isolated from the breast tissue of 69 year old Caucasian woman 
in the 1970’s and was assigned as MCF-7 after the Michigan Cancer Foundation- 
7 where the cell line was first established (Soule et al. 1973).  The donated 
cryovial was thawed quickly to 37°C as in 2.2.2 and seeded into a T75 flask with 
15mls pre-warmed DMEM/F12(1:1)1X medium (section 2.2.3.3).  For 
maintenance of MCF-7 cells, a seeding density of ~1 x 10
5
 cells took 
approximately 1 week grow to confluence and medium was replenished every 3-4 
days. 
A B 
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Figure 2.3 Phase contrast images of MCF-7 cell line. 
2.2.2 Recovery of cryopreserved cells  
Cryovials were quickly removed from liquid nitrogen storage and thawed to 37°C 
before being introduced into the appropriate volume and type of pre-warmed 
medium needed for each cell type, and gently mixed.  Cells were then left to 
adhere overnight/24 hours (T75 flasks were used unless otherwise stated) before 
the medium was changed to remove any residual dimethyl sulphoxide (DMSO) 
which had been used to previously cryopreserve the cells (2.2.7). 
2.2.3 Maintenance of cells in culture  
2.2.3.1 Human Bronchial Epithelial Cells (NHBE)  
NHBE cells were maintained in specialised serum-free BEGM medium and 
defined supplements (Lonza Clonetics®, BEGM® Singlequots® bulletkits).  
500ml bottles of BEGM were prepared (shelf life of approximately 3-4 weeks at 
4°C) by the addition of singlequots supplements containing: 0.2% bovine pituitary 
extract (BPE), 0.1% insulin, 0.1% hydrocortisone, 0.1% gentamycin sulphate and 
amphotericin-B (GA), 0.1% retinoic acid (RA), 0.1% transferrin, 0.1% triiodo-L-
thyronine, 0.1% epinephrine and 0.1% human recombinant epidermal growth 
factor in buffered bovine serum albumin saline solution (rhEGF).  BEGM medium 
was changed one day after seeding and then every other day to maintain viability. 
NHBE cells were passaged according to section 2.2.5 when they reached no more 
than 85% confluency as they become irreversibly contact-inhibited when grown to 
confluence.  The specialised subculturing reagents including HEPES buffered 
saline solution, Trypsin/EDTA and Trypsin neutralising solution (Lonza 
ReagentPack™) were used throughout.  
In addition, passage 8 NHBE cells were also cultured with a pre-prepared 
supplemented, serum-free basal medium (LHC-9 1X) from GIBCO for a period of 
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13 days alongside normal cell culture in Lonza BEBM medium.  It was noted that 
NHBE cells cultured in the GIBCO medium were morphologically different after 
1 passage, and although the majority of the cells continued to represent small 
basal cells, there was an increasing number of long, spindly (fibroblast-like) cells 
seen which were never present during BEGM culture.   The presence of these 
morphologically abnormal cells within the NHBE culture was also coupled with 
an increased time to reach the desired confluence to passage, and lower cell 
counts per ml than seen in the NHBE cells grown in Lonza medium, and 
increased floating dead cells within the culture.  As a result of this, it was decided 
to halt the culture of the cells in the GIBCO medium and dispose of the flasks.  
All cell culture of NHBE cells was continued using BEBM.  
2.2.3.2 Human dermal fibroblasts 
Normal human dermal fibroblasts were maintained in Dulbecco’s Modified Eagle 
Medium (DMEM), with phenyl red indicator and without l-glutamine; or low 
glucose DMEM, with GlutaMAX™, all supplied by GIBCO®, Invitrogen.  In 
order to maintain stable concentrations of L-glutamine in culture, GlutaMAX™ 
supplements (200mM L-alanyl-L-glutamine dipeptide in 0.85% NaCI) and 
medium were used as an alternative to L-Glutamine which breaks down quickly in 
culture to form ammonia.  Complete DMEM medium was made up with 10-15% 
fetal bovine serum (FBS), 1% penicillin/streptomycin, and 1% l-glutamine (or 1% 
GlutaMAX in non-supplemented media). 
2.2.3.3 Human breast adenocarcinoma cell line MCF-7 
MCF-7 cells were maintained in Dulbecco’s modified eagle medium/Hams F12 
(1:1) 1X supplemented with 10-15%FBS, P/S and L-glutamine/Glutamax.  
DMEM without phenol red was used as this can act as a weak oestrogen and may 
affect the proliferation of the oestrogen-receptor positive control cell line 
(Berthois, Katzenellenbogen & Katzenellenbogen 1986).   
2.2.4 Seeding Density  
In order to ensure normal growth of cells as a monolayer, as stated in section 
2.2.1.1, NHBE cells were seeded at a density of approximately 3500 cells/cm
2
, 
and 1HD/AGO1522 and MCF-7 cells on average between 1333-3500 cells/cm
2
.  
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A range of vessel sizes were used for experiments.  The seeding density of NHBE 
cells was also increased when a higher passage was reached or to accommodate 
for cell death during extended culture after exposure to ionising radiation. 
To calculate the volume (ml), of cell suspension needed for each flask to obtain 
the correct cell concentration per ml, the following equation was used: 
Total cells needed per flask  = Volume (ml) needed per flask 
Desired seeding density 
2.2.5 Harvesting Cells 
The old culture medium was removed and discarded into a beaker of Virkon 
disinfectant and the cell sheet washed twice with 10mls of Versene (0.197g 
EDTA per 1L of phosphate buffered saline [PBS]), being careful at all times not 
to touch the cell sheet with the pipette tips or to cause too much mechanical 
disruption to the cells.  For NHBE cells, the cell sheet was washed twice with 5-
10mls of HEPES-BSS (Lonza Clonetics®), and discarded.  It was important that 
these wash steps were not missed as the medium contains complex proteins and 
calcium that can neutralise and reduce the efficiency of the trypsin enzyme.  To 
enzymatically hydrolyse the connective proteins and dissociate adherent cells, 2-
3ml of a porcine trypsin 1X working solution or 2-3ml of the recombinant fungal 
trypsin-like serine protease TrypLE™ Express (GIBCO, Invitrogen) was added to 
fibroblast and MCF-7 cells. NHBE cells were dissociated specifically with 2-3 ml 
of Trypsin/EDTA (NHBE) (Lonza Reagent Pack™) per flask.  Flasks were 
incubated at 37°C (5% CO2) for 2-5 minutes and checked under phase contrast 
until 90% of the cells had rounded up.  The trypsin/TrypLE Express activity was 
neutralized with 4-6mls of DMEM with 10% FBS (2.2.3) for fibroblast/MCF-7 
cultures (TrypLE Express does not require deactivation with trypsin inhibitors), or 
4-6mls of Trypsin neutralizing solution (TNS, soybean derivative) (Lonza 
Reagent Pack™) for NHBE cultures. The cell suspension was then pelleted by 
centrifugation for 5 minutes at 1100rm (NHBE) and 10 minutes at 1200 for other 
cultures, before removal of the supernatant.  The cell pellets were then re-
suspended in a total of 1ml of fresh complete DMEM or BEBM medium for cell 
counting (section 2.2.6).  
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2.2.6 Cell Counts 
A 20µl aliquot of cell suspension was added to 20µl of Trypan blue (GIBCO, 
Invitrogen) gently mixed and added to a haemocytometer chamber for counting.  
Viable cells were counted in 4 of the large squares and the average multiplied by 
the dilution factor of trypan blue (1:2) and by a conversion factor of 10
4 
(0.1mm
3 
volume) or 5000 (0.2mm
3 
volume) to give the total number of cells per ml. 
Where possible, the percentage of viable cells was calculated by dividing the 
number of viable cells per ml by the total number of cells per ml (dead and alive), 
and multiplying by 100.  
According to the derived cell count, the volume of cell suspension required per 
new culture flask was calculated by: 
No. of cells needed       = volume (ml) per flask to obtain required seeding density. 
Total number of cells/ml 
2.2.7 Cryopreservation of cells 
Cells were prepared for cryopreservation after harvesting as described in section 
2.2.5 in sterile freezing cryovials at approximately 5 x 10
5
 – 1.5 x 106 cells per 
vial.  Cell pellets were re-suspended in fresh medium and the required volumes of 
cell suspension made up to 1ml with 10% DMSO.    The freezing mix of DMSO 
and fresh medium was left to sufficiently cool before addition of the cell 
suspension in order to reduce the cell damaging exothermic effects of DMSO that 
occur above room temperature.   Cryovials were immediately stored at -80°C for 
24 hours before being transferred to liquid nitrogen (-179°C) for permanent 
storage. 
2.2.8 Observations 
Regular observations were made of the cells in culture, especially for the more 
fragile NHBE cells, including cell morphology and % confluency to ensure cells 
were harvested at the correct time.  It was also essential to ensure that the cultures 
remained free of infectious agents such as bacteria/fungus by microscopic 
examination of the medium and cells.  The epithelial characteristics of NHBE and 
the predominance of large ‘fried egg’ goblet cells within the culture were both 
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noted as the occurrence of the latter increase within the ageing cultures or as a 
potential sign of differentiation. 
2.3 Cell-based Experimental Protocols 
2.3.1 Optimisation of senescence-associated beta galactosidase (SA-β gal) 
assay 
 
Positive controls 
Determination of an appropriate positive control was performed using MCF-7 
breast adenocarcinoma cell line/AGO1522 and 1HD dermal fibroblasts.  
According to manufacturer recommendations, MCF-7 cells were treated with a 
sub-lethal dose of the topoisomerase II inhibitor Etoposide (Ascent Scientific) to 
induce premature senescence.   Further optimisations were carried out using sub-
lethal doses of ethanol and hydrogen peroxide and the most effective method 
chosen. 
Etoposide treatment 
Old medium was discarded from sub-confluent culture wells of either MCF-7 or 
AGO1522/1HD dermal fibroblasts prior to treatment for 24 hours in 12.5μM 
Etoposide (2.5μl of 50mM Etoposide stock in DMSO, per 10 mls of medium).  
Etoposide medium was then removed carefully from wells and the cells washed 
twice with PBS, before adding fresh medium and cell recovery allowed for 4-5 
days.  Medium was replenished every 2 days and non-treated cells were 
trypsinised into a larger flask if necessary.  Cells were then fixed and stained 
according to the SA-β-gal chromogenic assay (section 2.3.1.1).  Use of MCF-7 
cells as a positive control for SA-β gal staining after etoposide treatment was not 
optimised due to the growth characteristics of the cells which resulted in 
subjective uniform staining. 
Ethanol treatment 
Sub-confluent cells were treated with 2-3 mls of 5% ethanol/DMEM mix for 2 
hours.  Treatment medium was removed and cells washed twice with PBS before 
addition of fresh medium.  This treatment was repeated everyday for a 5 day 
period, prior to staining. 
Hydrogen peroxide treatment 
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Sub-confluent cells were treated with 2-3 mls (per 35mm dish) of 150μM 
H2O2/DMEM medium mix for 2 hours.  After two PBS washes, medium was 
replenished and cells allowed to recover for 3-4 days. 
2.3.1.2 Cytochemical detection of SA-β gal 
Senescence β-galactosidase staining kit was sourced from Cell signalling 
Technology (BioLabs, UK) to stain for β-galactosidase activity at pH 6.0 in 
senescent cells.  The kit includes 10X fixative solution (20% formaldehyde, 2% 
gluteraldehyde in 10X PBS); X-gal powder (5-bromo-4-chloro-3-indoyly-β-D-
galactopyranoside, 20X, 20mg), which can be stored at -20°C in a light resistant 
container for 1 month as an X-gal in N-N-dimethlyformamide stock; 10X Staining 
solution (400mM Citric acid/sodium phosphate, at pH 6.0, 1.5 M NaCl, 20mM 
MgCl2); 100X staining solution supplement A (500mM potassium ferrocyanide) 
and 100X staining solution supplement B (500mM potassium ferricyanide).  
Whilst protected from direct light, the growth medium was removed from wells 
(all volumes given are for 35mm dishes) the cell sheets washed once gently with 
PBS and then fixed with 1ml of 1X fixative solution (10X diluted in distilled 
water) for 10-15 minutes at room temperature.  930μl of 1X staining solution 
(10X previously diluted with distilled water), 10μl of supplement A, 10μl of 
supplement B and 50μl 20mg/ml X-gal in DMF were made up to pH 6.0.  The 1X 
Fixative solution was removed from the wells and washed three times with PBS.  
1ml of the prepared staining solution at pH 6.0 was added to each well and 
incubated overnight (staining maximal after 12-16 hours) at 37°C without CO2 
and after incubation the cell sheets were washed three times with PBS.  Stained 
cell sheets were then washed briefly with methanol and allowed to air dry in the 
dark which enables dried slides to be kept for several months protected from the 
light.  The cells were then checked at 200X magnification for a blue precipitate 
using a light microscope and the percentage of SA-β gal positive cells was 
determined in at least 4-5 fields of view/or 200-400 cells (Positive SA-β-gal cells 
scored/total counted = % of positive SA-β-gal cells).  Positive control etoposide 
treated cells were stained at the same time as normal cells for each experiment.  
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2.3.2 Irradiation Protocols   
2.3.2.1 Preparation of cells for irradiation 
Glass microscope slides (Menzel) or coverslips were labelled with pencil for 
identification and then acid washed with gentle agitation in a 1:10 volume of 
HCl:dH2O for 30 minutes, then rinsed with sterile dH2O before being transferred 
to 100% Methanol at 4°C until needed.  Slides were flamed for sterilization before 
placement into quadriPERM® dishes (Sigma) or culture dishes/flasks,  prepared 
with 1 ml of warm medium in advance of seeding 8-8.4 x 10
4 
cells per slide 
(maintaining a seeding density of 3333-3500cells/cm
2
).  Where necessary to 
maintain cells in culture after IR for longer than one subculture, NHBE cells were 
also seeded into separate T25 flasks for IR at the seeding density described above, 
with subsequent dishes/slides prepared from these flasks according to the 
experiment endpoints required.    5-7 ml of BEBM or complete DMEM (see 
section 2.2.3), was added to each slide compartment/flask and quadriPERMs  
were incubated at 37°C in 5% CO2 for 2-3 days until cells reached  60-80% 
confluency for irradiation.  Medium was refreshed in accordance with 2.2.3.1 and 
2.2.3.2.   QuadriPERMs, flasks and dishes were prepared separately for shams and 
each dose, however all conditions were kept the same except that the sham slides 
were not exposed at the source. 
Prior to irradiation of prepared culture vessels, cell confluency was checked under 
the microscope to ensure that growth was sufficient, including allowance of a 
degree of cell death that may occur after exposure (dose-dependent). 
QuadriPERM dishes and prepared flasks were placed into thermally insulated 
boxes containing heat packs, and taken down to the relevant irradiation source.  
Sham slides were always transported with and treated in exactly the same way as 
the irradiated slides; however they were not irradiated at the source. When 
possible, a non-gassed 37°C incubator setup in position to keep the cells warm 
during radiation exposure was used.  This was to further reduce the shock/stress of 
low temperatures in the cells during transportation to and during treatment in the 
irradiation suite. 
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2.3.2.2 Low LET Gamma Exposure 
Cells were exposed to low-linear energy-transfer (LET) Cobalt-
60
 gamma rays 
using either the higher activity Co-60 source site (nomimal activity on 24
th
 June 
1999=1.9KCi,/70.3 TBq) or the lower activity cobalt-60 source (nominal activity 
on 27 Jan 2000 =  29.9 Ci/106 GBq) within Brunel University.  Half-life ( t1/2) = 
63.24 months.  The irradiation source that was used for individual exposures was 
dependent on the total dose required.  The higher activity Co-
60
 was used for 
exposures between 1-2 Gy (0.0933-0.0944 Gy/min dose rate) and the lower 
activity Co-
60
 was used for all exposures below 0.5 Gy thus far (0.101-0.111 
Gy/min dose rates).  The dose rate that all cells were exposed at was as kept as 
consistent between the two sources.  Dose rate, distance from source and exposure 
times were calculated using a Cobalt-60 Higher or lower activity chart, and 
dosimetry measurements for low dose exposures were performed by Dr Mark Hill 
and colleagues (Oxford University).   T0 was noted at the time of exposure and 
irradiated and sham vessels were quickly transferred back to the laboratory and 
incubated at 37°C in 5% CO2 for the desired experimental incubation time 
(30minutes – 33 days, see results for specific experimental details and fixation 
times)  prior to fixation with paraformaldehyde (PFA).   
2.4 Immunofluorescent Antibody Staining 
2.4.1 Fixation of cells 
The cell culture medium was removed and slides were gently washed three times 
with PBS then fixed by incubation with 4% paraformaldehyde (PFA) for 5-10 
minutes at room temperature (RT).  The slides further washed 3 times with PBS to 
remove the PFA, and then transferred to a 50ml tube containing fresh PBS and 
refrigerated at 4°C until needed for antibody staining.  
2.4.2 Permeabilisation of cells 
To enable penetration of the antibodies to the intra-cellular environment, cells 
were permeabilised by incubating with 0.5% Triton X-100 detergent in PBS for 5 
minutes at 4°C, followed by three times washes with cold PBS.  
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2.4.3 Antibody staining 
To detect the recruitment of the 53BP1 protein at sites of DNA double strand 
breaks a mouse anti-human 53BP1 antibody (Clone 19, BD Biosciences) and a 
secondary goat anti-mouse IgG tagged with the fluorophore Alexafluor568 was 
used.  In addition to incubation with antibodies against 53BP1 proteins, antibodies 
against a carboxyl terminal segment of Ki-67, a proliferative marker, were 
sourced. A primary polyclonal rabbit anti-human Ki-67 antibody (Nova Castra) 
and a secondary goat anti-rabbit IgG tagged with a fluorescin (FITC) (Invitrogen) 
were used.  Antibody containing tubes were centrifuged for 3-6 seconds prior to 
aliquoting to ensure that any aggregates had been spun down.   
Table 2.2 Antibodies used for immunofluorescence 
PRIMARY 
Raised in To Conjugate Optimal Dilution Antibody against 
Rabbit Ki-67 - 1:1500 Ki-67 
Mouse 53BP1 - 1:200 53BP1 
SECONDARY  
Goat Mouse AF568 1:200 53BP1 
Goat Rabbit FITC 1:200 Ki-67 
 
2.4.4 Antibody preparation    
100µl of primary and secondary antibody was required per microscope slide, so 
the total volume of antibody needed was adjusted according to slide number.  To 
prepare an antibody mix that allowed for antibody co-staining against both Ki-67 
and 53BP1 antigens, a 1:1500 dilution of primary Ki-67 (2.4.3) in blocking buffer 
(BB; 5% FBS in PBS) was prepared.  1µl of 53BP1 antibody was then mixed with 
199µl of 1:1500 Ki-67 antibody making a 200ul aliquot.  Secondary antibodies, 
goat anti-rabbit FITC (Ki-67) and goat anti-mouse AF568 (53BP1), were both 
used at a dilution of 1:200 (1µl of each secondary antibody was added to 198µl of 
blocking buffer). 
2.4.5 Blocking and Antibody incubation 
After permeabilisation (2.4.2) 200µl of BB was added to each slide, covered with 
parafilm and incubated at RT for 1hr in a moistened box, to prevent non-specific 
32 
 
antibody binding.  100µl of the primary Ki-67/53BP1 antibody preparation (2.4.3 
– 2.4.4), was added to each slide, covered with parafilm and incubated at RT for 1 
hour in a moist container.  The slides were washed 3 times with cold PBS to 
remove unbound primary antibody before dipping slides briefly in BB and then 
addition of 100µl of secondary antibody (section 2.4.3-2.4.4), covering with 
parafilm and incubation at RT for another hour.  After incubation, the slides were 
further washed 3 times with cold PBS with gentle agitation. 
2.4.6 Counterstain 
Excess PBS was removed from the antibody stained slides and gently patted dry.  
Slides were then mounted and chromatin counterstained each with 20-30µl of 
vectashield containing 4’6-diamidino-2-phenlylindole (DAPI) (VectorLabs), and 
covered with a glass coverslip.  The edges of each slide were sealed with nail 
varnish to prevent drying out, and the slide stored into a sealed darkened box at 
4°C until analysis.  Where necessary slides were labelled and coded, to remove 
bias during analysis. 
2.5 Immunofluorescent analysis 
Microscope slides for both 1HD and NHBE cell types for all experiments were 
initially visualised in the same way by manual analysis (2.5.1.1).  Later 
experimental work using irradiated NHBE included manual, as well as automated 
capture (Metafer v.4) and analysis systems (AutoRIF) (2.5.2-3).  Analysis of 
experimental slides enabled quantification of 53BP1 radiation-induced foci (RIF) 
number, as well as generation of linear measurements of size by automated 
analysis for the same manually scored data sets also.  Determination of the 
proliferative status of the cells, and the cell cycle stage was determined by 
manually classifying the Ki-67 staining of the same nuclei that RIF had been 
counted in.  All immunofluorescently-labelled slides were analysed manually by 
fluorescence microscopy, and then further analysed using automated capture 
Metafer v.4 software followed by AutoRIF analysis script (see results for exact 
experiment details and analysis options).  Graphs and tables were generated from 
raw data using Microsoft Excel and data was normalised to percentage where 
necessary to account for variations in total nuclei counted across experiments. 
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2.5.1 Manual analysis 
Slides for manual scoring were analysed using an Axioplan 2 –Zeiss 200M 
Fluorescent Microscope and cells were visualised using oil (Immersol, Carl Zeiss) 
immersion objectives at 63x and 100x magnification.  85-150 cell nuclei were 
scored manually per slide, using DAPI to locate cells nuclei.  DAPI located nuclei 
were then scored using TRITC and TR filters for 53BP1 stains, and FITC filter for 
Ki-67 staining. Images were captured using ISIS software according to the 
manufacturer’s directions.   
2.5.1.1 Manual Ki-67 analysis   
The Ki-67 staining patterns and their distribution types (type Ia, Ib and II), as 
described by Dr Joanna Bridger (1998) (Bridger, Kill & Lichter 1998) were used 
to determine the scoring criteria (Figure 2.4).  Ki-67 staining was categorised into 
Ki-67 negative cells (no visible nuclear FITC staining), type Ia, type Ib and type II 
Ki-67 positive cells (staining visible under FITC fluorescence as distinct staining 
patterns related to stage of the cell cycle), and minimal background fluorescence.           
             A: Type Ia                          B: Type Ib                      C:Type II 
  
Figure 2.4 Immumofluorescent images of Ki-67 staining patterns in sham NHBE 
cell nuclei: A, Type Ia, B Type Ib and C Type II as described in Bridger 1998 (Bridger, 
Kill & Lichter 1998).  Nuclei that were in very close proximity to one another were 
excluded from analysis. 
2.5.1.2 Manual 53BP1 foci analysis 
53BP1 foci were scored in both Ki-67 positive and negative nuclei.  53BP1 foci 
were scored directly by eye at 100x magnification in a 3D manner by scrolling 
through the nuclear focal plane.  The total number of foci was recorded per 
nucleus (100-150 nuclei).  Foci were not manually categorised by size due to time 
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constraints (Figure 2.5) however automated capture and analysis systems (2.7) for 
later experimental work provided added focus size information. 
 
Figure 2.5 Immunofluorescent image of 53BP1 foci in a NHBE cell nucleus: Foci 
were scored by manually by number and not by size (53BP1=red, chromatin=blue). 
2.5.2 Automated image acquisition 
Mounted and counter-stained slides as in 2.4.6 were immediately set up onto the 
Metafer v4 (JAI M4+ 8bit camera) (Metasystems) and this metaphase finder 
software was utilised to identify cell nuclei coordinates (stored as an MSD file).  
Once the slides were set up on the stage, the ‘MSearch’, ‘Fluorescence’ mode was 
selected and the correct classifier chosen to allow for scanning of the slide (in this 
case ‘single cells’ for finding nuclei).  Once an area on the slide had been defined 
at 10x magnification and the x and y coordinates for the area to be scanned 
determined, the microscope scanned the defined region and a gallery of all the 
‘Msearch’ DAPI-stained nuclei appears.  The ‘Msearch’ image gallery was 
checked and all out-of-focus and bad images were deleted for each slide prior to 
capture.  Images of nuclei were then automatically acquired using the ‘AutoCap’ 
mode, under the classifier ‘ArticleVAL (H2AX-TR-FITC) MIP’.  This classifier 
was set up to enable capturing of images using 3 filters (DAPI for chromatin, TR 
for 53BP1 foci and FITC for Ki-67), with exposure control as automatic for 
DAPI, and fixed for TR and FITC channels, where the Max. T integer/second was 
adjusted accordingly to prevent bleaching or overexposure of slides during image 
capture.  These exposure times were 0.7500, 0.063-0.0167 and 0.1667ms for all 
experimental slides for DAPI, TR and FITC respectively.  The exposure times for 
TR channel were adjusted to account for variations in fluorescence intensities 
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across experimental batches.  These exposure times for TR were determined by 
checking the intensity of foci in test images using Image J software and ensuring 
that foci were not deemed to be overexposed.  If this was the case then the 
exposure time was corrected accordingly and then all of the nuclei were 
autocaptured.   DAPI and FITC were set to 1 focus plane and TR was set to 20 
focal planes which allows for 20 z-stacks of 0.5µm step that are then collapsed to 
form a 2D maximum intensity projection (MIP) image.  Approximately 500-1000 
images were captured per time point and the saved image thumbnails were then 
manually scanned and any ‘out-of focus’/no nucleus present/poor 
contrast/dividing cell images were deleted.  The number of total images after 
quality checking varied.  The checked black and white images (untick ‘merged 
image’ option) were then saved as TIF files for processing using the AutoRIF 
analysis script.  Ki-67 was captured as a potential comparison for manual analysis 
with larger sample size, but not for automated analysis.  
2.5.3 Automated analysis script (AutoRIF) 
A java-based AutoRIF software program (McVean et al. 2012) was used to 
analyse each TIF image and count the number and size of 53BP1 foci within each 
nucleus.  In order to determine the optimal filtering iterations to be applied to each 
experiment, a number of nuclei per time-point and dose were batch tested as 
described below prior to running the whole experiment.  Although the optimal 
settings for each image will vary, the final filtering steps that were applied across 
an entire experiment were based on batch tested images and represented those that 
provided the minimum number of filtering steps without introducing artefacts, and 
these final settings were applied to all images within an experiment.  
2.5.3.1 Calculation of Histograms and analysis of images 
In order to process images acquired on the Metafer microscope by AutoRIF, a 
macro was written that organised each DAPI and TR image file into its own folder 
in a B/W TIF format.  AutoRIF visualises 2 channels where DAPI acts as a mask 
and the second channel shows the 53BP1 (TR) signal. 
A temporary digital folder was created for the histograms and images in advance 
of the ‘two-part’ AutoRIF processing.  Part 1 of the program was opened as 
shown in figure 2.6 ‘start_part1_512m or 1024m’ (depending on the speed of the 
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pc) and the folder with the images to be analysed was selected. A temporary 
folder was selected to determine the location of the histograms created during Part 
1.  The ‘image with foci’ option was selected where ‘even’ represents the foci 
channel and odd represents the DAPI channel in this instance.  The number of 
filtering iterations required were selected as determined by the batch test images 
and these settings were applied to all images within an experiment.   As a guide, 
increasing the Pre-filtering iterations reduce the high frequency noise in the 
original nucleus by smoothing the image repeatedly, laplasian sensitivity 
determines the sensitivity to the difference in noise, and post-filtering (Crimmins 
speckle removal) applies further smoothing to remove noise after the previous 
filters have been applied. 
   
Figure 2.6 Part 1 and 2 AutoRIF analysis script.  Part 1:  select the directory with 
the images in ‘choose dir with images’ and select the temporary directory that has been 
created ‘chose tmp dir’.   Select the temporary folder which will determine the location of 
the histograms.  Batch testing a selection of images for each time point was essential to 
ensure that the settings are correct before running the complete set of images.  Filtering 
iterations need to be optimised for each whole experiment and then the same settings 
applied to all images within an experiment.  Part 2: uses histograms generated in part 1 
to quantify data as excel output including nucleus number, nucleus area, nucleus height 
and width, focus number, focus area, focus intensity etc (example output in figure 2.7). 
Part 2 of the script converts the histograms and cropped original files into binary 
images that the data can then be extracted from.  To do this, Part 2 was run 
(start_part2_512m or 1024m), selecting 1 processor core (when running part 2 on 
the Zoostorm computer), and the temporary folder with the recently generated 
histograms was selected.  A name was generated for the new excel files that are 
propagated on completion of both parts of the propagated.  As the images were 
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captured as 2D MIP images, the excel output provided focus area information for 
each focus within a nucleus and x, y, z coordinates for 3D stacks. 
2.5.3.2 Automated Excel output 
Figure 2.7 shows an example of the excel output generated on completion of 
AutoRIF Part 2, showing foci intensity and area measurements in pixels for all 
foci counted within the images of each nuclei processed.  In order to confirm 
AutoRIF identification of a focus, the minimum intensity and size (pixels) 
thresholds for what is considered to be a focus must be determined and 
subsequently applied to all time-points within that experiment.  These may be 
different between batches and therefore a number of images were checked and the 
optimal settings were determined and applied to the whole experiment.  Once 
these were determined a series of IF (AND) equations will return focus area only 
if it is above both the minimum intensity and size cut-offs.  Further equations to 
group the focus areas into small (<0.5µm = min size-50 pixels), medium (0.5 – 
1.0µm = 51-100 pixels), and large (>1.0µm = 100+ pixels) were applied.  
Calculation of average foci number per nucleus and the proportion of small, 
medium and large foci were based on nuclei with one or more focus. Finally, only 
foci that satisfied both the minimum size and intensity requirements described 
above were included within these calculations.     
 
Figure 2.7 Example excel output using AutoRIF analysis script.  A different tab is 
automatically generated for each time point that is analysed within the whole experiment.  
If focus area (G) and intensity (I) are above minimum intensity cut-off (V1 – determined 
by user) and size (V3) then filtered area (L) is returned and will be included in calculation 
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of average area and foci/nucleus.  If focus area or intensity does not exceed minimum 
values, then cell is left blank and categorised as not being a true focus.   
2.6 Statistical analysis 
Statistical analysis was carried out where possible using a non-paired, two-tailed 
Student T-test (P<0.05 is significant).  Statistics were calculated using Microsoft 
Excel or GraphPad QuickCalcs online statistical calculator. 
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3 Results 
3.1 Cell Culture 
3.1.1 NHBE cells in culture 
Primary NHBE cells were obtained from Lonza (2.2.1.1) and maintained in 
NHBE medium (2.2.3.1) at a seeding density of 3500 cells/cm
2
.  The NHBE cells 
were maintained for experimental procedures from passage 5 (considered to be 
mid passage) up to passage 10/11 (late passage) (figure 3.2 A and B).  In order to 
look at the effect of radiation at extended times, NHBE cells were also cultured 
continuously up to passage 13, which equated to a total of 40 days in culture.   
Donor 2 (D2) and donor 3 (D3) NHBE were maintained in continuous culture for 
a period of 17 and 32 days respectively to calculate cumulative cell growth (figure 
3.3), while cells from passage 4-13 (D3, n = 2 experiments) were also stained with 
SA-β-gal (2.3.1.1) to show evidence of an increasing percentage of senescent cells 
with each passage.   
  
 
 
 
 
 
 
 
 
Figure 3.1 Normal human bronchial epithelium.  The normal differentiated airway 
epithelium is made up of three different epithelial cell types including basal, mucous-
producing Goblet cells and ciliated epithelial cells (Picture adapted from Vaughan MB, 
2006) (Vaughan et al. 2006).
 
 
A B 
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Figure 3.2  NHBE cell morphology in young and ageing cells.  Image A = passage 4 
NHBE cells with a distinct cobblestone appearance made up predominantly of small basal 
epithelial types, and image B= passage 10 NHBE cells with a larger proportion of large, 
goblet cells visible than in younger cultures. Scale bar = 25µm. 
 
The cumulative total growth for D2 NHBE cells was calculated over 17 days and 
5 passages, representing a cell population doubling time of 36 hours and ~11 
population doublings (PDs).  D3 NHBE cells were cultured over 32 days and 6 
passages corresponding to ~18 PDs and a population doubling time of ~41 hours.  
These calculations do not account for plating efficiency and are representative of 
cumulative population doublings only. Therefore the actual PDs that the NHBE 
cells will go through during this period observed are considerably less, with 
Lonza stating that NHBE cells will go through a total of 18 and 15 PDs for D2 
and D3 respectively (table 2.1). 
 
Figure 3.3   Cumulative normalised cell growth curves for NHBE cells in normal 
monolayer culture and after sham, 0.3 and 0.5 Gy γ-ray exposure.   Donor 2 (P4-9; 
red squares) and Donor 3 (P7-13; grey triangle, black square, blue diamond, and green 
triangle and P4-P10, green triangle) NHBE cells were maintained in cell culture and 
counted at each subsequent passage.  Cells were stained with Trypan blue and viable cells 
counted.  
 
To determine the effect of IR on the growth of NHBE cells, cultures at P7 (figure 
3.3) were seeded into T25 flasks for exposure to sham, 0.3 and 0.5 Gy γ-rays as 
described in 2.3.2.1 and 2.3.2.2 for subsequent processing for analysis of 53BP1 
foci, Ki-67 proliferative and SA-β gal status at extended times after IR (2.4 and 
2.3.1.2).  Cell populations were therefore maintained in culture enabling the 
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generation of cumulative growth curves after radiation exposure. Similar to above, 
these do not take into account plating efficiency and represent cumulative PDs 
during culture period only.  The cumulative PDs were similar to those seen during 
normal monolayer culture of both D2 and D3, although it is apparent that the 
population growth of sham-treated cells appears to slow ~20 days in culture, 
relative to irradiated populations. 
3.1.2 Cellular senescence of NHBE during normal subculture 
3.1.2.1 SA β- galactosidase staining of Etoposide treated 1HD fibroblasts 
Optimisation of the SA-β galactosidase assay was performed in 1HD fibroblasts 
(figure 3.4 and 3.5).  To act as a positive control, cells were treated with etoposide 
to induce premature cellular senescence prior to staining for SA-β gal activity 
(2.3.1-2.3.1.2).  
  
Figure 3.4 SA-β gal staining of etopisode (12.5µM) treated 1HD dermal 
fibroblasts.  Senescent fibroblast shown by the presence of a blue precipate indicating 
the presence of lysosomal SA-beta-galactosidase activity at pH 6.0.  
Figure 3.5 shows that treatment with 12.5μM of etoposide (as suggested by 
manufacturers) is as effective as treatment with 20μM in our cell type.  16% of 
non-treated control 1HD cells stained positive for SA-β gal (categorised as 
senescent), in contrast to 76% of fibroblasts treated with 12.5 or 20µM of 
etoposide.  We therefore concluded that a 24 hour treatment with 12.5µM of 
etoposide followed by a 4-5 day recovery prior to fixation was sufficient to induce 
cellular senescence above that of the control treated cells. 
SA-β gal 
negative 
1HD cell 
Senescent SA-
β gal positive 
1HD cell 
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Figure 3.5 Effect of etoposide concentration on the induction of premature 
senescence in 1HD fibroblasts (P21).        
3.1.3.1 SA β-galactosidase staining of normal NHBE cells 
In order to determine the baseline level of senescent cells within NHBE cells and 
to quantify how this fraction of senescent cells changes with each passage, D3 P4-
P7 NHBE cells were stained with X-gal to detect SA-β-galactosidase activity at 
pH 6.0 as described in 2.3.1.1.  In addition to determining a baseline senescent 
fraction within normal NHBE culture, P7 NHBE cells exposed to sham, 0.3 and 
0.5 Gy γ-rays were stained for SA-β gal at each passage up to 33 days after IR to 
determine if there was any indication of premature senescence after our moderate 
dose exposures (figure 3.6).  
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Figure 3.6 SA-β-gal staining of D3 NHBE cells with increasing passage (P4-P13) 
after sham, 0.3 and 0.5 Gy γ-ray exposure.  Cells were irradiated at P7 (red dashed 
line), and SA-β gal dishes were prepared at each subsequent passage (P8 onwards). Cells 
were fixed from 8 days after exposure to sham (black lines/squares), 0.3 Gy (red 
line/squares) and 0.5 Gy (green line/triangles) IR.  Sham P4-P7 (purple line/circles) 
represent the SA-β gal positive fraction of NHBE cells during normal subculture in an 
independent experiment, and all data points represent one measurement.  No SA-β gal 
measurements were obtained at T0 in P7 NHBE cells due to insufficient cell counts. 
11% of P4 NHBE stained positive for SA-β gal activity, which subsequently 
increased to 21% at P7 (purple lines/circles) (figure 3.6 and 3.7).  This increase in 
SA-β-gal staining was coupled with an enlarged morphology of the blue stained 
positive cells possibly representing an increasing number of NHBE reaching their 
finite replicative capacity and entering senescence.  Although this method is 
extremely subjective and therefore requires that large numbers of cells are scored, 
Ki-67 immunofluorescent staining which is absent in senescent cells, correlates 
with this.  Specifically, 16 - 36% (average 25%) of cells were Ki-67 negative at 
P6, increasing to ~57% in ageing (P10) shams (range 43-62%) (figure 3.26).  
Comparatively, 14% of sham NHBE cells at P8 were positive for SA-β gal 
activity which subsequently increased to 36 % at P12.  Figure 3.6 shows that 
although there is obvious variability in the percentage of senescent cells in P7 and 
P8 NHBE cell populations (2 separate experiments) in sham and irradiated nuclei, 
the fraction of senescent cells within both of these populations of cells increases 
with the same trend (20% and 24% at P8 increasing to 44% and 39% in P12 
NHBE cells exposed to 0.3 and 0.5 Gy respectively).  The increase in SA-β gal 
positive NHBE with increasing passage represents an increase in the percentage 
of senescent cells within the culture, with age, however there does not appear to 
be any signs of an increasing percentage of senescent cells after a single acute 
dose of radiation (0.3 or 0.5 Gy).  Notably, there is a decrease in the fraction of 
SA-β gal activity in P13 sham (33%) 0.3 Gy (35%) and 0.5 Gy (26%) exposed 
cells compared to P12 nuclei (figure 3.6).  This may represent a technical loss of 
SA-β gal positive cells during passage or a loss of the senescent cells from the 
population by apoptosis.  In order to determine whether this decrease/plateau is a 
result of maintaining the cells in continuous culture and to account for the 
variation that is seen between cell dishes, it is necessary to increase the number of 
dishes analysed at each time point, as well as replication of the observations 
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independently.  This effect is also seen in the NHBE cells stained for Ki-67 after 
continuous culture (section 3.4).                  
 
Figure 3.7 SA-β-gal staining in P7 NHBE cells.  Magnification x200 
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3.2 Induction and persistence of 53BP1 foci in NHBE cells of varying 
passage age after exposure to γ-rays 
To determine the frequency of radiation-induced damage in NHBE cells of 
varying age, cells were exposed to 0 – 2 Gy of Co60 γ-rays (~0.1 Gy/min dose 
rate).  Cells were seeded onto acid-washed and flamed microscope slides or T25 
flasks for extended culturing as described in 2.3.1 and transported for IR at 70-
80% confluency (2.3.2 and 2.3.3).  The sham slides were always treated in exactly 
the same way as the irradiated slides however they were not irradiated at the 
source. Cells were fixed according to section 2.4.1 at varying times post-
irradiation and antibody stained using anti-53BP1 in order to determine the 
induction and persistence of DNA DSB after exposure.  
Table 3.1 Summary of Irradiations performed using donor 3 NHBE cells of 
varying passage number 
Passage 
at 
Exposure 
Cobalt 
60 
source 
used 
Total 
dose 
(Gy) 
Dose 
rate 
(Gy/min) 
Total 
exposure 
time 
(minutes) 
Fixation times 
(hours) 
End points 
5 
Lower 
activity 
0.3 + 
0.5 
0.111 
2.36 + 
4.22 
0.5, 24 , 48 
53BP1 foci 
number and 
size; % Ki-67 –
ve cells 
6 
Lower 
activity 
0.3 + 
0.5 
0.110 
2.40 + 
4.29 
0.5, 24, 29* 
53BP1 foci 
number and 
size; % Ki-67 –
ve cells  
10 
Lower 
activity 
0.3 + 
0.5 
0.105 
2.47 + 
4.41 
0.5, 48, 216 
53BP1 foci 
number and 
size; % Ki-67 –
ve cells 
10 
Higher 
activity 
2 0.1304 15.34 0.5, 48, 168 
53BP1 foci 
number and 
Ki-67 
7 
Lower 
activity 
0.3 
+0.5 
Gy 
0.101-
0.104 
2.83+4.9 
(Quads); 
2.83 
+4.77 
(T25)  
0-792 (33 days) 
53BP1 foci 
number and 
size; % Ki-67 –
ve cells; % SA-
β gal +ve cells  
Table 3.1 summarises the experimental details and end points studied using NHBE cells 
reported in the results section.  * 29 hour fixation taken instead of 48 hrs as cells would 
be more than 85% confluent at 48 hrs. 
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3.2.1 Induction of 53BP1 foci in mid passage NHBE cells  
In order to determine the effect that IR has on the induction of 53BP1 foci ~100 
P5 and 6 NHBE nuclei were manually analysed per dose and timepoint for the 
number of 53BP1 foci per nucleus after exposure to sham, 0.3 and 0.5 Gy γ-rays 
and fixed after 0.5, 24 and 48/29 hours for P5/P6 cells.   
3.2.1.1 Effect of exposure to 0.3 and 0.5 Gy 
In order to check that there was no adverse damage induced in shams as a result of 
the transportation to the irradiation source, a Time 0 sham was scored giving an 
average of 1 53BP1focus/nucleus, which was in concordance with the other shams 
at all timepoints (table 3.2). Exposure of mid passage NHBE cells to 0.3 and 0.5 
Gy resulted in a significant induction of DNA DSB as detected by an increase in 
53BP1 foci compared to shams (table 3.2 and figure 3.8).  Specifically, the 
number of 53BP1 foci increased from 1.2 foci per nucleus in mid-passage sham 
nuclei, to 5.3 and 6.5 foci per nucleus after 0.3 and 0.5 Gy respectively at 30 
minutes post exposure (graph 3.8). Thus the number of 53BP1 foci induced was 
similar for cells exposed in P5 and P6 (Table 3.2 and pooled graph 3.8).   By 24 
hours, the average number of 53BP1 foci had returned to sham levels after 0.5 Gy 
(1.3 foci/nucleus).  However, after 0.3 Gy the average number of 53BP1 foci (1.7 
foci/nucleus) was still significantly different to the 24 hour sham (unpaired, two-
tailed t test, p=0.0118) possibly suggesting a higher number of DSB that have yet 
to be repaired and resolved.  Given this was not seen in cells fixed at 29 hours or 
at 48 hours, it is more likely that this reflects the variability in foci seen in NHBE 
cells.   
 
 
 
 
 
 
47 
 
Table 3.2 Average number of 53BP1 foci in mid passage NHBE cells after 0.3 
   and 0.5 Gy 
Age of 
NHBE 
Timepoint (PI) 
and dose 
Average number 
of 53BP1 
foci/nucleus  
Passage 5 
(n=100) 
Sham 30mins 1.22 
Sham 24hr 0.77 
Sham 48hr 1.06 
0.3 Gy 30 5.29 
0.3 Gy 24hr 1.17 
0.3 Gy 48hr 1.00 
0.5 Gy 30 mins 6.76 
0.5 Gy 24hr 0.87 
0.5 Gy 48hr 1.37 
Passage 6 
(n=100) 
T0 1.0 
Sham 30 mins 1.1 
Sham 24hr 1.5 
Sham 29hr 1.3 
0.3 Gy 30m 5.3 
0.3 Gy 24hr 2.2 
0.3 Gy 29hr 1.2 
0.5 Gy 30 mins 6.2 
0.5 Gy 24hr 1.8 
0.5 Gy 29hr 1.2 
   
 
Figure 3.8 Average number of 53BP1 foci in mid passage NHBE cells after 0.3 
and 0.5 Gy.  0.5 hr and 24 hour sham, 0.3 and 0.5 Gy are averages calculated from 
independant experiments (n=2) . 24 hours after exposure to 0.3 Gy, average number of 
53BP1 foci counted in 100 nuclei was statistically significant from foci number in sham 
nuclei after 24 hours (p=0.0118). * = Two-tailed p value = <0.05, statistically significant 
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compared to sham at same timepoint.  Error bars represent SD of the mean based on 2 
independent experiments. 
 
 
Figure 3.9 Distribution of 53BP1 foci in mid passage sham nuclei.  53BP1 foci 
distribution is the same in mid passage nuclei (T0-48hr), with the majority of NHBE cells 
containing between 0-2 foci per cell (38-53% of nuclei contained no 53BP1 foci at all 
time points).  Graph is for comparison between all mid passage shams. 
After IR, the induction of DNA damage is shown by the increasing number of 
nuclei with increasing numbers of 53BP1 foci by 30 minutes and an apparent dose 
effect which returns to a similar distribution to the shams by 24hrs (Figure 3.9 and 
3.10).  The elevation of average number of foci (figure 3.10) which was still 
significant to sham at 24 hours after 0.3 Gy can be accounted for by an increase in 
nuclei with 2 foci.  Nuclei with above 30 foci per nucleus were excluded as they 
were seen in both irradiated and sham cells and thought to be S phase cells; these 
accounted for <5% in all experiments. 
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Number of 53BP1 foci in NHBE cells 
Figure 3.10 Distribution of 53BP1 foci number in mid passage NHBE nuclei after 
exposure to 0.3 Gy and 0.5 Gy γ-rays.  Distribution profiles are from P5 sham and 
exposed nuclei.  P5 distribution profiles are representative of P6 profiles (data not 
shown). 
3.2.2 Induction and persistence of 53BP1 foci in late passage NHBE cells 
after exposure to γ-rays.  
P10 NHBE cells were exposed to sham, 0.3 Gy and 0.5 Gy γ-rays and fixed at 
varying times (30 minutes-216 hours) after IR and stained for the detection of 
53BP1 foci (2.4). 150 nuclei per time-point were analysed by manual scoring 
methods (2.5.1.2). 
The distribution of foci in late passage sham exposed cells was shown to be 
between 2-4 foci/nucleus (table 3.3 and figure 3.13) compared to 0-2 foci in mid 
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passage cells (figure 3.10).  By 30 minutes post exposure there is evidence of a 
significant induction of DNA damage (p=0.0001) after 0.3 Gy (6.86 foci/nucleus) 
and 0.5 Gy (8.21 foci/nucleus) which is also higher than the average foci number 
seen in mid passage cells (figure 3.8 and 3.11).  It is likely that the increase in 
background foci in the aged cells (P10 at time of IR) accounts for this (figure 
3.12).  These cells were fixed over a period of 216 hours (9 days), with a cell 
passage separating the 48 hour and 216 hour time points.   Again as seen with 
younger mid passage cells (P5/6), by 48 hours the average number of 53BP1 foci 
had returned to sham levels. However interestingly 216 hours after exposure to 
0.5 Gy the average foci scored was elevated (4.73 foci/nucleus, p=0.0001) 
compared to the 216 hour sham (3.31 foci/nucleus), possibly representative of the 
appearance of new foci.  That said, variability was observed between shams at 
different time points e.g. between 30 minute and 48 hour (p=0.0007) and 30 
minute and 216 hour (p=0.0012) shams, meaning such interpretation must be 
considered with caution. 
 
Table 3.3 Average number of 53BP1 foci in late passage NHBE cells after  
  exposure to 0.3 and 0.5 Gy 
Age of 
NHBE 
Timepoint (PI) 
and dose 
Average 
number of 
53BP1 
foci/nucleus  
Modal 
average 
number of 
53BP1 
foci/nucleus 
Passage 
10/11 
(n=150) 
Sham 30 mins 2.44 0 
Sham 48 hr 3.43 2 
Sham 216 hr 3.31 3 
0.3 Gy 30 min 6.86 7 
0.3 Gy 48hr 3.95 3 
0.3 Gy 216 hr 3.57 4 
0.5 Gy 30 min 8.21 7 
0.5 Gy 48 hr 4.03 2 
0.5 Gy 216 hr 4.73 3 
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Figure 3.11 Average number of 53BP1 foci in late passage NHBE cells up to 216 
hours after γ-ray exposure. n=1. 
The distribution of foci in sham and exposed NHBE cells are shown in figure 
3.12.  The background distribution is fairly consistent for all sample time points, 
however it is higher compared to mid-passage cells with only ~24% of late-
passage sham nuclei having zero foci (15-34%), compared to ~50% of mid 
passage nuclei (38-55%) (figure 3.10).  The increase in the background and 
broader distribution patterns in later passage cells may make distinction of 
radiation effects more difficult, particularly at low dose exposures.  Again, by 216 
hours after 0.5 Gy, it is possible to see a shift in the distribution of NHBE cells 
with more nuclei with increased numbers of foci compared to sham 
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Number of 53BP1 foci in NHBE cells 
 
Figure 3.12 Distribution of 53BP1 foci number in late passage NHBE nuclei after 
exposure to 0.3 Gy and 0.5 Gy γ-rays.  Sham is the same sample on both 0.3 and 0.5 Gy 
graphs. X axis = Number of 53BP1 foci in NHBE nuclei, y axis = percentage of NHBE 
cells scored (NHBE cells scored = 150 per sample). 
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3.2.3 Induction and persistence of 53BP1 foci in NHBE cells up to 33 days 
after irradiation. 
In addition to looking at the difference between induction and decline of 53BP1 
foci in mid and late passage NHBE cells, it was necessary to determine if there 
was an increase or persistence in the number of DNA damage foci after irradiation 
at extended times compared to sham treated NHBE.  Passage 7 NHBE cells were 
exposed to sham, 0.3 and 0.5 Gy γ-rays on either glass slides in Quadriperms (24-
48 hr fixation) or in T25 flasks (for continuous culture) and fixed for  co-staining 
for 53BP1 and Ki-67 analysis up to 792 hours after exposure (table 3.4).   
The 30 minute-48 hr timepoints in table 3.4 represent the pooled averages from 
independent analysis of 53BP1 foci in P4-P7 NHBE cells after 0.3 and 0.5 Gy.  
The average number of 53BP1 foci 48 hours after exposure to 0.3 Gy (1.64 
foci/nucleus; pooled 1.32 foci/nucleus) and 0.5 Gy (1.44-1.47 foci/nucleus) are 
both significant (P=0.0047 and P=0.00277 for 0.3 and 0.5 Gy respectively) 
compared to sham (1 focus/nucleus).  However the average number of 53BP1 foci 
in sham nuclei  196 hours (1.68 foci/nucleus) after IR is no different to that seen 
by the same time  after 0.3 Gy (1.7 foci/ nucleus) and 0.5 Gy (1.69 foci/nucleus).  
This further highlights interpretative issues when dealing with very small numbers 
of foci.   
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 Table 3.4 Average number of 53BP1 foci in NHBE cells up to 792 hours after 
   sham, 0.3 and 0.5 Gy γ-rays. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.4 196 – 792 hr timepoints represents manual analysis from one continuous 
experiment.  Averages calculated at 0.5, 24 and 48 hr timepoints represent pooled data 
from both mid passage NHBE experiments (figure 3.8) and longterm analysis where 
applicable (n=2-3).   
Cell 
type NHBE cells (P7-P13) 
Dose γ-
rays 
Time 
after IR 
(hrs) 
Average number 
of 53BP1 foci per 
nucleus 
Sham 
(n=100) 
0.5 1.17 
24 1.11 
48 1.00 
196 1.68 
384 1.51 
528 2.17 
624 1.43 
696 1.14 
792 1.23 
0.3 Gy 
(n=100) 
0.5 5.27 
24 1.39 
48 1.32 
196 1.70 
384 1.67 
528 1.17 
624 1.28 
672 0.91 
792 0.48 
0.5 Gy 
(n=100) 
0.5 6.46 
24 1.36 
48 1.44 
196 1.69 
360 2.00 
480 1.03 
552 0.95 
648 1.14 
720 0.80 
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Figure 3.13 Manual analysis of average number of 53BP1 foci in NHBE cells (P5-
P13) up to 792 hours after sham, 0.3 and 0.5 Gy exposure.  Error bars represent SD of 
the mean from 2 (0.5 and 48 hour) and 3 (24 hr) independent experiments.  Variation is 
large due to the spread of foci in samples. 
Figure 3.13 and figure 3.14 highlight the average number and distribution profiles 
of 53BP1 foci in NHBE nuclei  up to 792 hours (33 days) after exposure to sham, 
0.3 and 0.5 Gy.  Both the average number and distribution profiles 24 hours after 
IR are consistent with sham average foci numbers and distribution.  Interestingly, 
there is a clear reduction in the number of foci in all dose groups (sham 1.43-1.23 
foci/nucleus, 0.3 Gy 1.17-0.48 foci/nucleus, 0.5 Gy 1.03-0.8 foci/nucleus) from 
528 hrs (P10) compared to earlier timepoints.  This reduction is not consistent 
with the increased background foci seen in sham and irradiated late passage nuclei 
(3.2.2), and thus cells irradiated at P7 and grown to P13 contain significantly less 
foci than seen in cells IR at late passage.  In mid passage NHBE cells, ~ 50% of 
sham nuclei have zero foci (figure 3.10), which correlates with the number of 
NHBE cells with zero foci by 24 hours in sham (51%) 0.3 Gy (50%) and 0.5 Gy 
(35%) P7 exposed nuclei.  Comparatively only 23% of late passage NHBE nuclei 
had zero foci (figure 3.12) and this proportion of cells with zero foci in later 
passage cells is not seen in the NHBE cells continuosly subcultured to late 
passage.  528 hours after sham exposure, 17% of nuclei contained 3 foci, 
compared to 5-11% of nuclei at all other timepoints analysed.  The increase in 
nuclei scored with 3 foci accounts for the average number of foci in sham nuclei 
(2.17 foci/nucleus) being significantly different to 0.3 Gy 528 hours (1.17 
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foci/nucleus, P= 0.0013) and 0.5 Gy 480 hours (1.03 foci/nucleus, P=0.0005) after 
exposure.  Thus, although this experiment spans the P10 age of NHBE cells, the 
data represents observations taken over 6 passages, whereas the earlier 
experiments were irradiated and fixed within one cell passage.  This may indicate 
that during continued subculture, the cells with an increased background are either 
removed from the cell population as a result of cell death (possibly apoptosis) or 
due to continued culture.  It is interesting to note that this decline occurred in all 
three independent cell populations (sham, 0.3 and 0.5 Gy) around the same time 
and therefore may represent an effect of continued culture on differentiation 
statuses of the cells.  Overall though, there is no evidence of any increase in 
number of 53BP1 foci  up to 33 days after a single exposure of 0.3 and 0.5 Gy γ-
rays.   
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Number of 53BP1 foci in NHBE cells 
Time after IR 
 
Figure 3.14 Distribution profiles of 53BP1 foci in NHBE cells up to 792 hours after 0.3 and 0.5 Gy γ-ray exposure.  
 150 NHBE cell nuclei scored per timepoint. 
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3.2.3 Effect of exposure to 2 Gy 
P10 NHBE cells were fixed for indirect-immunofluorescence 0.5, 48 and 168 
hours after exposure to sham and 2 Gy γ-rays. 
DNA damage can be seen by an increase in 53BP1 foci in NHBE nuclei (11.21 
foci/nucleus) 30 minutes after exposure to 2 Gy which is significantly different 
(P=<0.0001) to sham levels at this time (1.77 foci/nucleus) (figure 3.15).  As seen 
after 0.3 and 0.5 Gy exposures, the number of foci (2.63 foci/nucleus) had 
returned to sham (2.21 foci/nucleus) after 48 hours in culture. By 168 hours, there 
is suggestion of a significant increase in the number of 53BP1 foci (3.24 
foci/nucleus) (as was seen at 216 hours in late passage cells after a dose of 0.5 
Gy), compared to sham (2.4 foci/nucleus, p=0.0108).  This can also be seen in the 
distribution graph (figure 3.16) whereby there is an obvious increase in the 
number of NHBE cells that still contain 6-8 53BP1 foci compared to sham at 168 
hours.  However as this experiment would need to be replicated to determine 
significance (n=1). 
 
Figure 3.15 Average number of 53BP1 foci in NHBE nuclei up to 168 hours after 
sham and 2 Gy exposure. 
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                              Number of 53BP1 foci in late passage NHBE cells 
 
Figure 3.16 Distribution of 53BP1 foci in late passage NHBE cells after exposure to 
sham and 2 Gy γ-rays. 
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3.3 AutoRIF analysis of DNA damage in mid and late passage NHBE cells 
To increase the number of nuclei analysed and also to gain information on the size 
of 53BP1 foci, images of nuclei from mid and late passage NHBE (3.2.1 and 
3.2.2) were automatically acquired using Metafer v4.0 software (2.5.2), enabling 
subsequent automated analysis of 210-1000+ images using AutoRIF (McVean et 
al. 2012) (2.5.3-2.5.3.2).  A series of pre-processing steps and batch testing of 
~10% of images from each time point were performed according to 2.5.3.1 and 
2.5.3.2 and the optimum settings were determined and applied to the whole 
experiment. AutoRIF then generated an excel output that provided statistics on 
each focus that is filtered to be above the minimum size and intensity thresholds 
previously set by the user. 
    
                         
Figure 3.17 Example AutoRIF cropped and threshold images.  A+B; Mid passage: 
0.3 Gy 30 min example images.  Minimum settings determined by batch testing were 1 
pre-processing, medium laplasian sensitivity and 1 post filtering iteration.  The minimum 
intensity threshold was determined as 89 and the minimum size was > than 6 pixels in 
area.  C+D. Late passage: 0.5 Gy 30 min example images.  Minimum settings 
determined as 2 pre-processing, medium laplasian sensitivity, and 1 post-filtering 
iteration.  These initial settings determine the foci output, and then user defined minimum 
intensity and size cut-offs further determine what is classified as a focus.  Image B 
highlights a focus that has been included in the threshold image but which will be 
excluded as it is below the minimum size cut-off (i).   Image C shows a focus that would 
not be quantified by AutoRIF as it is below the required intensity (ii).  Cropped image ~ 
1320 x 1030 pixels in size. 
B A
  A 
C D 
(i) 
(ii) 
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3.3.1 Quantification of 53BP1 foci in mid passage NHBE cells by AutoRIF 
analysis 
210-598 mid passage NHBE nuclei were analysed by AutoRIF for 53BP1 foci and 
compared with that previously obtained by manual analysis (table 3.5 and 3.3).  A 
slightly lower average number of 53BP1 foci was seen 30 minutes after 0.3 Gy 
exposure (4.13 foci/nucleus compared to 5.3 foci/nucleus for AutoRIF and manual 
analyses respectively), while a significantly higher number was seen 30 minutes 
after 0.5 Gy  (9.2 foci/nucleus compared to 6.8 foci/nucleus, P=0.0145) for 
AutoRIF and manual analysis respectively).  Such differences may be as a result 
of a far larger population of nuclei being analysed by AutoRIF than by manual 
analysis and the inclusion of a higher proportion of smaller foci (discussed in 
section 3.5).   Correlation between AutoRIF and manual analysis was seen 24 
hours (1.63 foci/nucleus) after 0.3 Gy and 48 hours (1.05 and 0.96 foci/nucleus) 
after 0.3 and 0.5 Gy respectively, whereby AutoRIF determined that the average 
number of 53BP1 foci had decreased to sham (1.24 and 1.22 foci/nucleus in 24 
and 48 hour sham). 
Table 3.5  AutoRIF analysis of mid passage NHBE cells after exposure to 0.3 
   and 0.5 Gy. 
Dose and time of fixation after IR exposure 
Total 53BP1 foci counted by 
AutoRIF 
Sham IR 0.3 Gy IR 0.5 Gy 
30 min 24 hr 48 hr 30 m 24 hr  48 hr 30m 24 hr 48 hr 
Total nuclei scored 
NA 
598 483 301 440 406 516 210 346 
Total small foci 689 481 1134 634 385 2863 255 292 
Total medium foci 40 81 100 61 30 1397 37 22 
Total large foci 14 27 10 21 11 466 11 18 
Total foci in all nuclei 743 589 1244 716 426 4726 303 332 
Average 53BP1 foci/nucleus                   
Average Small foci 
NA 
1.15 0.99 3.75 1.44 0.95 5.54 1.21 0.84 
% Small foci  93 82 91 89 90 61 84 88 
Average Medium foci 0.07 0.17 0.33 0.14 0.07 2.71 0.18 0.06 
% Medium foci 5 14 8 9 7 30 12 7 
Average Large foci 0.02 0.06 0.03 0.05 0.03 0.90 0.05 0.05 
% Large foci 2 5 1 3 3 10 4 5 
Average Foci/nucleus in all 
nuclei 
1.24 1.22 4.13 1.63 1.05 9.16 1.44 0.96 
Average foci/nucleus (manual 
score) 
1.22 0.77 1.06 5.29 1.17 1.00 6.76 0.87 1.37 
Average 53BP1 foci in foci 
positive nuclei only 
NA 
2.54 2.64 5.00 3.19 2.40 10.48 2.70 1.97 
% of foci positive nuclei 49.00 46.58 83.06 51.14 43.84 88.57 53.81 48.84 
Average Small foci 2.35 2.15 4.55 2.82 2.17 6.37 2.27 1.73 
Average Medium foci 0.14 0.37 0.40 0.27 0.17 3.09 0.33 0.14 
Average Large foci 0.05 0.13 0.04 0.09 0.06 1.02 0.10 0.11 
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Table 3.5 summarises the average number of 53BP1 foci in mid passage NHBE cells as 
determined by AutoRIF analysis (No 30 minute sample was available for AutoRIF 
analysis due to slide breakage).  The average number of 53BP1 foci determined by 
manual analysis of the same samples has been show for comparison.  Focus size 
information has been represented here for section 3.5. 
 
As shown in figure 3.18 the number of normal sham mid passage NHBE nuclei 
with 1 or more focus is 48%, which as expected increases to 83% and 89% 30 
minutes after 0.3 and 0.5 Gy respectively, as a result of an increase in the number 
of nuclei containing damage.  24 hours after exposure this remains elevated at 
51% (0.3 Gy) and 54% (0.5 Gy) but by 48 hrs the number of nuclei containing 
foci has returned to sham levels as damage is resolved to background. 
 
Figure 3.18 Percentage of mid passage NHBE cells with 1+ foci up to 48 hours after 
sham, 0.3 and 0.5 Gy exposure. 
Figure 3.19 shows the distribution profiles of 53BP1 foci in mid-passage NHBE 
cells whereby 50-60% of sham nuclei have zero foci, and the remaining nuclei 
contain ~2-4 foci, directly correlating with the distribution of nuclei with zero foci 
detected by manual analysis (figure 3.10).  After the shift in distribution of 53BP1 
foci to the right as a result of IR exposure, the irradiated cells appear to have a 
similar distribution of 53BP1 foci to the sham cells at both 24 hours and 48 hours, 
supporting the earlier analysis that repair of the induced damage was completed 
by this time.  
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Number of 53BP1 foci  
Figure 3.19 Distribution of 53BP1 foci in mid passage NHBE cells (AutoRIF). 
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3.3.2 Quantification of 53BP1 foci in late passage NHBE cells by AutoRIF 
analysis  
In order to determine if there was an increase in 53BP1 foci background in aged 
NHBE cells as determined by manual analysis, the same samples were analysed 
using the automated capture and analysis script (section 2.5.2-2.5.3.2).  Late 
passage NHBE cells analysed by AutoRIF showed a great deal more variation 
compared to the manual counts obtained in late-passage cells.  This could reflect 
greater statistics for AutoRIF due to the increased numbers of cells and therefore 
may better reflect the actual amount of damage present or by contrast it may 
reflect technical issues with AutoRIF.  The increased background seen in ageing 
sham nuclei may test the limits of the analysis program after lower dose 
exposures.  Specifically, the average number of foci per nucleus at 30 minutes 
was 6.31 and 9.75 after 0.3 and 0.5 Gy respectively for AutoRIF (table 3.7) 
compared to 6.86 and 8.21 foci/nucleus scored manually (table 3.3 and figure 
3.11).  The average number of foci scored at 48 hours (4.13 foci/nucleus) and 216 
hours (5.57 foci/nucleus) after 0.3 Gy, and 48 hours (5.23 foci/nucleus) after 0.5 
Gy remains elevated compared to shams.  However there is greater variation in 
sham background foci at all sampling times (range 2.55-4.29 foci/nucleus) 
compared to manual analysis (range 2.44-3.31 foci/nucleus). 
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Table 3.6 AutoRIF analysis of late passage NHBE after exposure to 0.3 and 0.5 
  Gy. 
AutoRIF analysis of late passage NHBE cells 
Dose and time of fixation after exposure 
Total 53BP1 foci 
counted by 
AutoRIF 
Sham IR 0.3 Gy IR 0.5 Gy 
30 
min 
48 hr 216 hr 30 m 48 hr 216 hr 30m 48 hr 216 hr 
Total nuclei scored 367 496 511 529 372 418 460 545 306 
Total small foci 1302 969 1613 2607 1200 1886 3336 2398 843 
Total medium foci 183 217 399 584 224 296 896 313 192 
Total large foci 78 80 180 149 114 146 254 138 107 
Total foci in all 
nuclei 
1563 1266 2192 3340 1538 2328 4486 2849 1142 
Average 53BP1 
foci/nucleus 
                  
Average Small foci 3.54 1.95 3.15 4.92 3.22 4.50 7.24 4.39 2.75 
% Small foci  83 77 74 78 78 81 74 84 74 
Average Medium 
foci 
0.50 0.44 0.78 1.10 0.60 0.71 1.95 0.57 0.63 
% Medium foci 12 17 18 17 15 13 20 11 17 
Average Large foci 0.11 0.05 0.21 0.11 0.17 0.14 0.21 0.12 0.14 
% Large foci 5 6 8 4 7 6 6 5 9 
Average 
Foci/nucleus in all 
nuclei 
4.26 2.55 4.29 6.31 4.13 5.57 9.75 5.23 3.73 
Average 
foci/nucleus 
(manual score) 
2.44 3.24 3.31 6.86 3.95 3.75 8.21 4.03 4.73 
Average 53BP1 
foci in foci positive 
nuclei only 
4.98 3.19 4.87 6.85 4.64 6.00 10.61 5.75 4.33 
% of foci positive 
nuclei 
86.10 80.65 88.65 93.01 89.78 93.54 93.04 91.38 86.60 
Average Small foci 4.15 2.44 3.59 5.35 3.63 4.86 7.90 4.84 3.19 
Average Medium 
foci 
0.58 0.55 0.88 1.19 0.67 0.77 2.11 0.63 0.73 
Average Large foci 0.25 0.20 0.40 0.31 0.34 0.37 0.60 0.28 0.40 
Table 3.6 summarises the average number of 53BP1 foci in late passage NHBE cells as 
determined by AutoRIF analysis. The average number of 53BP1 foci determined by 
manual analysis of the same samples has been show for comparison.  Focus size 
information has been represented here for section 3.5. 
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Figure 3.20   Percentage of late passage NHBE cell nuclei with more than one focus 
up to 216 hrs after 0.3 and 0.5 Gy exposure.  
 
Interestingly, the percentage of late passage NHBE cells (figure 3.20) with more 
than 1 focus present does not change as markedly as with the mid passage cells 
(figure 3.18) after exposure to 0.3 or 0.5 Gy.  80-88% of late passage sham nuclei 
contain more than 1 focus, compared to 47-49% in mid passage sham nuclei.  This 
again highlights the increased background level of 53BP1 foci in the late passage 
NHBE nuclei and also suggests that these radiation doses do not necessarily 
induce damage foci in all nuclei or the damage may be repaired in a proportion of 
nuclei prior to our earliest observation at 30 minutes. 
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Number of 53BP1 foci in late passage NHBE cells 
Figure 3.21 Distribution of 53BP1 foci in late passage NHBE cells after exposure to 0.3 Gy and 0.5 Gy (AutoRIF). 
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The frequency distribution graphs (3.21) of 53BP1 foci in ageing late-passage 
NHBE cells up to 216 hours after exposure to 0.3 and 0.5 Gy show an increase in 
the number of cells with increased 53BP1 foci in both sham and irradiated cells, 
compared to mid-passage NHBE exposed to the same dose. In late-passage sham 
nuclei there is a decrease in nuclei with zero foci compared to mid passage cells.  
This increase in background damage foci in late passage cells is shown by only 
14, 19 and 11% of sham nuclei containing zero foci.  In concordance with manual 
analysis however, 52, 64 and 53% of sham nuclei at 30 minutes, 48 hours and 216 
hours respectively had between 2-4 foci.  The initial induction of DNA damage 
after 0.5 Gy as determined by AutoRIF analysis shows a flattened distribution of 
foci with NHBE nuclei, therefore the NHBE cell nuclei contain a large variation 
of foci number.  At 30 minutes, the majority of nuclei (53%) contained between 6-
12 foci, and 29% contained between 12-16 foci which is comparable to manual 
analysis.  Interestingly, it is clear from the graphs that 48 hours after exposure to 
0.5 Gy, the distribution profile has not yet returned to sham, with 45% of the 
nuclei still containing between 4-7 foci and the trend appears similar to that seen 
30 minutes after 0.3 Gy exposure.  However, after 216 hours 56% of nuclei 
contained between 2-4 foci which is representative of sham.    
3.3.3 Quantification of 53BP1 foci in NHBE cells up to 792 hours after 
exposure by AutoRIF analysis  
In order to quantify 53BP1 foci number and size at extended times after IR 
exposure, ~500-2000 cell nuclei were analysed per timepoint by AutoRIF up to 
the extended time of 33 days after IR, with the exception of ~200 nuclei captured 
at 24 hr due to available cell numbers (see table 3.5 and 3.6 for exact numbers for 
each timepoint).  As shown in table 3.7 AutoRIF analysis has shown no further 
increase in 53BP1 foci number up to 792 hrs after 0.3 Gy and 0.5 Gy exposure.  
By 24 hours after IR, P7 NHBE cells show generally good concordance with 
manual analysis after sham (1.23 foci/nucleus) compared to 1.10 foci/nucleus, and 
after 0.5 Gy (1.06 foci/nucleus) compared to 1.34 foci/nucleus for AutoRIF and 
manual analyses respectively).  The average number of 53BP1 foci 24 hr after 0.3 
Gy was slightly higher (1.28 foci/nucleus) than manual (0.75 foci/nucleus) but 
this is more than likely due to the smaller cell sample size at this time which will 
impact on the average foci numbers scored when not all nuclei will contain foci.  
AutoRIF analysis also determined that there was a reduction in average number of 
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53BP1 foci approximately 360 hours (P9) after exposure to all doses, which was 
seen during manual analysis also.  
 
70 
 
Table 3.7    AutoRIF analysis of NHBE cells cultured for up to 792 hours after 0.3 and 0.5 Gy exposure 
Dose and time of fixation after exposure 
Total 
53BP1 foci 
counted by 
AutoRIF 
Sham 0.3 Gy 0.5 Gy 
24 
hr 
48 hr 196 hr 384 hr 528 hr 624 hr 696 hr 792 hr  24 hr 48 hr  196 hr 384 hr 528 hr 624 hr 672 hr 792 hr 24 hr 48 hr 196 hr 360 hr 480 hr 648 hr 720 hr 
Total nuclei 
scored 
190 567 405 1302 1040 964 1578 1870 120 410 767 734 2173 1963 1081 1324 249 453 631 1000 2336 1158 1458 
Total small 
foci 
204 445 407 1372 757 515 760 855 138 383 990 700 1472 1284 397 653 213 538 778 832 1319 813 844 
Total 
medium foci 
26 92 87 273 106 87 118 140 11 68 164 111 193 148 61 103 33 75 147 158 228 110 86 
Total large 
foci 
5 27 19 92 38 54 71 88 5 18 31 32 105 86 38 43 17 23 40 55 117 45 55 
Total foci in 
all nuclei 
235 564 513 1737 901 656 949 1083 154 469 1185 843 1770 1518 496 799 263 636 965 1045 1664 968 985 
Average 
Small foci 
1.06 0.78 1.00 1.05 0.73 0.53 0.48 0.46 1.14 0.93 1.29 0.95 0.68 0.65 0.37 0.49 0.85 1.19 1.23 0.83 0.56 0.70 0.58 
% Small 
foci  
87 79 79 79 84 79 80 79 90 82 84 83 83 85 80 82 81 85 81 80 79 84 86 
Average 
Medium 
foci 
0.14 0.16 0.21 0.21 0.10 0.09 0.07 0.07 0.09 0.17 0.21 0.15 0.09 0.08 0.06 0.08 0.13 0.17 0.23 0.16 0.10 0.09 0.06 
% Medium 
foci 
11 16 17 16 12 13 12 13 7 14 14 13 11 10 12 13 13 12 15 15 14 11 9 
Average 
Large foci 
0.03 0.05 0.05 0.07 0.04 0.06 0.04 0.05 0.04 0.04 0.04 0.04 0.05 0.04 0.04 0.03 0.07 0.05 0.06 0.06 0.05 0.04 0.04 
% Large 
foci 
2 5 4 5 4 8 7 8 3 4 3 4 6 6 8 5 6 4 4 5 7 5 6 
Average 
Foci/nucleus 
in all nuclei 
1.23 0.99 1.27 1.33 0.87 0.68 0.60 0.58 1.28 1.14 1.54 1.15 0.81 0.77 0.46 0.60 1.06 1.40 1.53 1.05 0.71 0.84 0.68 
Average 
foci/nucleus 
(manual 
score) 
1.10 0.95 1.68 1.51 2.17 1.43 1.14 1.23 0.75 1.64 1.70 1.67 1.17 1.28 0.91 0.48 1.34 1.47 1.69 2.00 1.03 1.14 0.80 
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Table 3.7   continued: 
Dose and time of fixation after exposure 
Total 
53BP1 
foci 
counted 
by 
AutoRI
F 
Sham 0.3 Gy 0.5 Gy 
24hr 
48 
hr 
196 
hr 
384 
hr 
528 
hr 
624 
hr 
696 
hr 
792h
r  
24 
hr 
48hr  
196 
hr 
384 
hr 
528 
hr 
624 
hr 
672 
hr 
792 
hr 
24 
hr 
48 
hr 
196 
hr 
360 
hr 
480 
hr 
648 
hr 
720 
hr 
Average 
53BP1 
foci in 
foci 
positive 
nuclei 
only 
2.13 1.93 2.15 2.21 1.95 1.77 1.62 1.69 2.31 2.06 2.30 2.02 1.93 1.98 1.46 1.68 1.77 2.31 2.36 1.94 1.80 2.01 1.86 
% of foci 
positive 
nuclei 
58.1
2 
51.8
5 
59.01 60.98 44.52 38.59 37.52 34.44 
55.8
3 
56.1
0 
67.54 57.08 42.29 39.33 31.64 36.03 
59.8
4 
61.3
7 
65.45 54.40 39.77 41.71 36.69 
Average 
Small 
foci 
1.85 1.52 1.71 1.74 1.64 1.39 1.29 1.34 2.06 1.68 1.92 1.68 1.60 1.67 1.16 1.38 1.43 1.95 1.90 1.54 1.43 1.69 1.59 
Average 
Medium 
foci 
0.23 0.32 0.36 0.35 0.23 0.23 0.20 0.22 0.18 0.30 0.32 0.27 0.21 0.20 0.18 0.22 0.22 0.27 0.36 0.30 0.25 0.23 0.16 
Average 
Large 
foci 
0.05 0.09 0.08 0.12 0.08 0.15 0.12 0.14 0.07 0.08 0.06 0.08 0.12 0.11 0.11 0.09 0.11 0.08 0.10 0.10 0.13 0.09 0.10 
Table 3.7 shows the average number and size of 53BP1 foci in NHBE cells after exposure to 0.3 and 0.5 Gy and fixed between 24-720 hours. 
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Figure 3.22     Percentage of NHBE cells with more than one focus up to 792 hrs after 0.3 
and 0.5 Gy exposure. 
The percentage of NHBE nuclei with 1+ foci 24-384 hours (P7-P9) after sham (range 
52-61%), 0.3 Gy (56-67%) and 0.5 Gy (60-65%) (figure 3.22) was seen to be higher 
than the percentage of mid passage sham (47-49%), 0.3 Gy (44-51%) and 0.5 Gy (49-
54%) that contained 1 + foci (3.18).  This may be as a result of an age related increase 
in the number of nuclei that contain foci.  However, as also described previously by 
manual analysis, there is a reduction in the number of NHBE cells with more than one 
focus from 528 hours onward at all doses which may be as a result of loss of the cells 
which contain 1+ foci or resolution of these foci.  This can also be seen in the 
distribution plots, whereby the distribution of foci in consistent with sham, with the 
number of nuclei with foci decreasing even at extended times.  This may represent 
ongoing repair, or the removal of the nuclei with foci from the proliferating population. 
 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
80
2
4
4
8
1
9
6
3
8
4
5
2
8
6
2
4
6
9
6
7
9
2
2
4
4
8
1
9
6
3
8
4
5
2
8
6
2
4
6
7
2
7
9
2
2
4
4
8
1
9
6
3
6
0
4
8
0
6
4
8
7
2
0
Sham IR 0.3 Gy IR 0.5 Gy
 N
H
B
E
 c
el
ls
 w
it
h
 1
+
 5
3
B
P
1
 f
o
ci
 (
%
) 
 
Time after IR (hr) 
73 
 
 
Number of 53BP1 foci in NHBE cell nuclei 
Figure 3.23 Distribution profiles of NHBE cells up to 792 hours after exposure to sham, 0.3 and 0.5 Gy. 
No 0.5 Gy sample at P11 analysed by AutoRIF due to slide breakage (~624 hr), 
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3.4 Influence of ionising radiation exposure on cellular proliferation 
In order to determine whether exposure to moderate to low doses of IR had any effect 
on the proliferative status of NHBE, and further to classify and visualise any trend in 
proliferative status with DNA DSB burden, 100-150 NHBE nuclei of varying passage 
were stained with primary antibodies rabbit anti human (Ki-67) or in combination with 
mouse anti human (53BP1) as described in 2.4.1.  Secondary antibodies for the co-stain, 
goat anti rabbit (FITC) and goat anti-mouse AF568 were also prepared as a single 
aliquot.   The visualised cells were then manually scored for their Ki-67 staining 
patterns using the FITC filter, and positive Ki-67 cells further categorised into type Ia, 
type Ib, or type II staining patterns as described by Bridger (Bridger, Kill & Lichter 
1998).  53BP1 nuclear foci were manually scored as described in 2.6.2, by scrolling 
through the focal plane in a 3D manner for the same nuclei as scored for Ki-67 staining.  
Ki-67 proliferative staining and the number of 53BP1 foci per nuclei were classified in 
NHBE 0- 792 hours after exposure to 0 - 2 Gy γ-rays.  
3.4.1 Ki-67 Staining in NHBE cells 
Table 3.7 shows the Ki-67 negative and positive cells scored for mid passage (P5-P6) 
and late passage (P10/11) NHBE after sham and γ-ray exposure.  The fraction of Ki-67 
negative (non-proliferating cells, NP) in mid-passage nuclei is 25% (range 16-36%) 
(figure 3.25) compared to an average of 57% in late passage cells (range 43-62%)  
(table 3.8 and figure 3.26), highlighting the increase in the number of Ki-67 negative 
cells in cultures of increasing passage age.  There appears to be no difference between 
the fraction of Ki-67 negative and positive cells at T0 compared to 30 minute shams, as 
well as by 30 minutes after exposure to 0.3, 0.5 and 2 Gy compared to sham, 
highlighting that there is no immediate change in the fraction of NP cells after exposure. 
216 hours after exposure of late passage NHBE cells to 0.3 Gy, the Ki-67 negative 
fraction is shown to be 73% compared to 61% in sham, which may represent an 
increase in the NP fraction of cells at later times after 0.3 Gy exposure.  This is not seen 
216 hours after 0.5 Gy, which is consistent with sham fractions scored (61%).  
Therefore, although the fraction of NP cells increases with age as expected, there is no 
clear evidence of an increase in NP cells after IR for the duration of analysis as 
visualised by Ki-67 at the sampling times thus far examined.   This is also the case after 
exposure to a higher dose of 2 Gy visualised over 168 hours where the fractions of Ki-
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67 negative cells were the same for both sham and irradiated nuclei, with the exception 
of a contrasting increase in the Ki-67 positive fraction 30 minutes after exposure (55% 
Ki-67 negative) compared to sham (43% Ki-67 negative) (table 3.8 and figure 3.27).  
Although NHBE cells grow as a non-synchronous culture, which may also account for 
the slight variation between samples in sham nuclei for Ki-67 scoring, ~70-90% of the 
total proliferating cells were scored as being of type II distribution (where Ki-67 is 
restricted to the nucleoli in late G1, G2 and S phases of the cell cycle, data not shown), 
irrespective of passage age or radiation exposure.  This may correspond with FACS data 
from our group that showed ~80% of cells to be in G1 phase during normal subculture.  
The remaining small fraction of proliferative cells were stained predominately as type Ib 
cells, and a consistently small fraction of cells were scored with type Ia distribution 
representative of very early G1, again irrespective of passage age in sham and irradiated 
nuclei. 
Table 3.7 Proliferative status of mid passage NHBE cells after exposure to 0.3 and  
 0.5 Gy. 
 
 
 
 
 
 
                    
 
 
 
 
 
 
 
 
Age of 
NHBE 
Timepoint (PI) and 
dose 
Number of Nuclei scored (%) 
Ki-67 
negative 
Total Ki-67 positive 
Passage 5 
(n=100) 
Sham 30mins 26 74 
Sham 24hr 16 84 
Sham 48hr 21 79 
0.3 Gy 30 38 62 
0.3 Gy 24hr 23 77 
0.3 Gy 48hr 27 73 
0.5 Gy 30 mins 30 70 
0.5 Gy 24hr 39 61 
0.5 Gy 48hr 33 67 
Passage 6 
(n=100) 
T0 32 68 
Sham 30 mins 36 64 
Sham 24hr 18 82 
Sham 29hr 23 77 
0.3 Gy 30m 35 65 
0.3 Gy 24hr 22 78 
0.3 Gy 29hr 46 54 
0.5 Gy 30 mins 37 63 
0.5 Gy 24hr 30 70 
0.5 Gy 29hr 23 77 
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Table 3.8 Proliferative status of late passage NHBE cells after exposure to 0.3, 0.5  
 and 2 Gy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.24 Fraction of Ki-67 negative NHBE cells in sham nuclei of varying passage age. 
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Age of 
NHBE 
Timepoint (PI) and 
dose 
Number of Nuclei scored (%) 
Ki-67 
negative 
Total Ki-67 positive 
Passage 10 
(n = 150) 
Sham 30 mins 43 57 
Sham 48 hr 59 41 
Sham 168 hr 61 39 
2 Gy 30 mins 55 45 
2 Gy 48 hr 60 40 
2 Gy 168 hr 57 43 
Passage 
10/11 
(n=150) 
Sham 30 mins 56 44 
Sham 48 hr 62 38 
Sham 216 hr 61 39 
0.3 Gy 30 min 51 49 
0.3 Gy 48hr 63 37 
0.3 Gy 216 hr 73 27 
0.5 Gy 30 min 46 54 
0.5 Gy 48 hr 62 38 
0.5 Gy 216 hr 61 39 
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Figure 3.25 Senescent fraction (Ki-67 negative) of mid passage NHBE cells up to 48 
hours after 0.3 and 0.5 Gy exposure.  Sham 0-48 based on average of n=2. 
  
Figure 3.26 Senescent fraction (Ki-67 negative) in late passage NHBE cells up to 216 
hours after 0.3 and 0.5 Gy exposure. N=1. 
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Figure 3.27 Senescent fraction (Ki-67 negative) of late passage NHBE cells up to 168 
hours after 2 Gy exposure. N=1. 
The Ki-67 negative fraction of NHBE cells during continued subculture for up to 792 
hours after sham, 0.3 and 0.5 Gy exposure is shown in table 3.9 and figure 3.28.  Cells 
were irradiated at P7 and then cultured to P13 and stained for Ki-67 as described in 
2.5.1 and 2.5.1.1.   The fraction of Ki-67 negative nuclei at P7 after sham (39%), 0.3 Gy 
(33%) and 0.5 Gy (39%) appears to correlate with the range seen in previous Ki-67 
stained mid passage cells (table 3.7; range = 16-46%) and is therefore suggestive of a 
gradual increase as expected.  These observed fractions appear to remain relatively 
unchanged up to approximately 384 hours (corresponding to P9)  after sham, 0.3 and 
0.5 Gy exposure, albeit the variation that is clearly seen (range 33-53% Ki-67 negative) 
up to this time.  However, most notably after this point there does not appear to be any 
further evidence of an increase in the number of Ki-67 negative cells with increasing 
passage, and as such, the late passage P10 Ki-67 fractions (range 28-37%) do not reflect 
those seen previously in cells of similar passage age (table 3.8; range = 43-73%).  
Instead the fraction of Ki-67 negative cells in P10-P13 NHBE cells appears to remain 
almost constant before dropping to 18-30% Ki-67 negative by 792 hours (P13).  These 
later results are therefore not representative of what has been previously shown and 
suggests that differences in the culture duration of the NHBE may impact on the 
preservation of NHBE (namely non-proliferating Ki-67 negative) cells within culture.  
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Table 3.9 Proliferative status of P7 NHBE cells exposed to 0.3 and 0.5 Gy and  
  cultured to P13.  
Dose 
Time 
after IR 
Percentage 
Ki-67 negative 
Sham 
24 39 
48 50 
196 30 
384 41 
528 28 
624 35 
686 27 
792 18 
0.3 Gy 
24 33 
48 37 
196 34 
384 53 
528 37 
624 34 
672 33 
792 30 
0.5 Gy 
24 39 
48 39 
196 51 
360 40 
460 29 
552 27 
648 31 
720 19 
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Figure 3.28 Senescent fraction (Ki-67 negative) of NHBE cells up to 792 hours after 0.3 
and 0.5 Gy exposure. 
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3.4.2  Distribution of 53BP1 foci in proliferating and non-proliferating NHBE cells. 
Co-staining NHBE with antibodies against Ki-67 and 53BP1 as described in 2.4 
allowed us to further classify cells with DSB burden into their proliferative status and to 
determine if there was any trend between cells with increased or persisting DSB burden, 
and the stage of the cell cycle they were in. 
In mid (figure 3.29), late (figure 3.30), and mid-late (figure 3.32A-C) passage NHBE 
cells that were exposed to sham, 0.3 and 0.5 Gy, and late passage NHBE exposed to 2 
Gy (figure 3.31), it is possible to visualise the distribution of 53BP1 DNA damage foci 
in both proliferative (Ki-67 positive, green line) and non-proliferative (Ki-67 negative, 
blue line) cells and see how this changes over time.  Irrespective of passage age and 
dose, the induction of 53BP1 DNA damage foci was shown to be the same in both 
proliferating and non-proliferating (senescent) NHBE cells showing that damage is 
induced to the same efficiency irrespective of proliferative status. The trends shown in 
figure 3.29 alter according to cell passage whereby Ki-67 positive cells dominate in 
mid-passage cells while Ki-67 negative cells dominate in late passage cells (figure 3.30 
and 3.31).  This therefore correlates with negative cells containing the majority of the 
foci by late passage.  According to the graphs, there is no obvious difference in the 
processing of 53BP1 foci in mid passage cells however there is a suggestion that 
processing of foci and DSB may be altered between proliferating and senescent cells in 
late passage cells.  Specifically, up to 216 hours after 0.5 Gy, the number of senescent 
NHBE cells that contain >6 foci per nucleus, remains higher than in sham nuclei. 
 
In order to determine if there was any increase in DNA damage burden in either Ki-67 
negative or positive cells at later times after IR, NHBE were observed up to 792 hours 
after IR.  The distribution of 53BP1 foci in both Ki-67 negative and positive NHBE (P7 
onwards) shows the same distribution as seen in NHBE irradiated at mid passage (P5).  
However, approximately 384 hours (P9) after all dose exposures the number of Ki-67 
negative cells actually decreases at each passage rather than increases, as shown before.  
As a result of the Ki-67 negative data not being consistent with previous experimental 
results it is difficult to determine if this is a real effect of the cells being removed from 
the population by apoptosis, or due to technical design.   As previously shown by our 
data and the literature, the fraction of Ki-67 negative cells within an ageing culture will 
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increase as the culture becomes senescent and therefore it is probable that a technical 
error in passage has meant that the whole cell populations have not been removed from 
the flasks at passage and their numbers decreased with each passage, or that senescent 
Ki-67 negative NHBE cells do not continue to adhere during frequent subculture.  As a 
result, NHBE cells at the later observation times represent the Ki-67 positive population 
containing foci.  As with NHBE cells exposed at mid passage and late passage, the 
distribution of 53BP1 foci is the same in both senescent (Ki-67 negative) and 
proliferating (Ki-67 positive) NHBE up to 792 hours after IR (figure 3.32A-C), and 
there is no increase in Ki-67 negative NHBE with increased damage burden up to 792 
hours after 0.3 Gy (figure 3.32B) and 0.5 Gy (figure 3.32C) compared to sham (figure 
3.32A).   
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Number of 53BP1 foci in Ki-67 –ve and +ve NHBE nuclei. 
Figure 3.29 Mid passage Ki-67 and 53BP1 co-stained NHBE nuclei after 0.3 and 0.5 Gy. 
Blue line represents Ki-67 –ve nuclei and green line represents Ki-67 + nuclei. 
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Number of 53BP1 foci in Ki-67 –ve and +ve NHBE nuclei. 
 
Figure 3.30 Late passage Ki-67 and 53BP1 co-stained NHBE nuclei after 0.3 and 0.5 Gy. 
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Number of 53BP1 foci in Ki-67 –ve and +ve NHBE nuclei. 
 
Figure 3.31 Late passage Ki-67 and 53BP1 co-stained NHBE nuclei after 2 Gy. 
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Number of 53BP1 foci in Ki-67 –ve and +ve NHBE nuclei. 
 
Figure 3.32A Long-term analysis of Ki-67 and 53BP1 co-stained sham NHBE nuclei. 
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Number of 53BP1 foci in Ki-67 –ve and +ve NHBE nuclei. 
 
Figure 3.32B Long-term analysis of Ki-67 and 53BP1 co-stained NHBE nuclei after 0.3 Gy. 
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Number of 53BP1 foci in Ki-67 –ve and +ve NHBE nuclei. 
 
Figure 3.32C Long-term analysis of Ki-67 and 53BP1 co-stained NHBE nuclei after 0.5 Gy. 
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3.5 Average size of 53BP1 foci in mid and late passage NHBE determined by 
AutoRIF analysis. 
As well as looking at the increase in DSB burden in NHBE cells after exposure to 
ionising radiation, the AutoRIF analysis system also allowed calculation of focus size 
(represented here in pixel size).  This therefore allowed us to further classify foci into 
size integers and determine if there is a dose or time-related increase in focus size, or 
persistence of larger 53BP1 foci after exposure to 0.3 and 0.5 Gy.  This will also allow 
us to see if there is any difference between the focus size in young and aged cells so far.  
In order to categorise focus area which were generated within an excel output sheet 
from running part 2 of the AutoRIF analysis script, the focus sizes were categorised into 
small (6-50 pixels = <0.5µm), medium (51-100 = 0.5-1.0µm) and large (100+ = 
>1.0µm) categories as described in 2.5.3.2.  The size categories, along with the 
minimum intensity and minimum size thresholds that are determined for each 
experiment by the user, allow for any foci that are not above the minimum thresholds to 
be excluded.  Anything above these thresholds is then grouped into the categories 
according to size.  
 
Figure 3.33 AutoRIF analysis of average 53BP1 foci number in foci positive mid passage 
NHBE cells up to 48 hours after 0.3 and 0.5 Gy exposure.  Average number of small, 
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medium and large foci counted in mid passage (P5) foci positive NHBE cells by AutoRIF.  
Dashed lines represent average number of small (blue line; 2.25), medium (red line; 0.25) and 
large (green line; 0.09) 53BP1 foci in mid passage foci positive sham NHBE nuclei only.  NB: 
there is no 30 minute sham for AutoRIF of mid-passage NHBE (due to slide breakage); the 24 
hour sham shall be used.   
 
Figure 3.34 AutoRIF analysis of 53BP1 foci size in foci positive mid NHBE cells up to 48 
hours after exposure to 0.3 and 0.5 Gy. 
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Figure 3.35 AutoRIF analysis of average 53BP1 foci number in foci positive late passage 
NHBE cells up to 216 hours after 0.3 and 0.5 Gy exposure.  Average number of small, 
medium and large foci counted in late passage (P10) foci positive NHBE cells by AutoRIF.  
Average number of small (blue line; 3.39), medium (red line; 0.67) and large (green line; 0.28) 
53BP1 foci in late passage foci positive, sham NHBE nuclei.   
 
Figure 3.36 AutoRIF analysis of 53BP1 foci size in foci positive mid NHBE cells up to 216 
hours after exposure to 0.3 and 0.5 Gy. 
As represented by figure 3.39A the average focus area (pixels)  is 22 and 33 pixels in 
mid passage 24 hour and 48 hour shams, compared to 34, 40, and 44 pixels  in late 
passage 30 minute, 48 hr and 216 hour shams (table 3.6 and figure 3.39B).  This 
therefore represents a high proportion of small foci that are less than 0.5µm in size.  The 
average foci area after 0.5 Gy exposure in young cells is significantly higher than all 
other shams and irradiated cells over the 48 hour observation period.  There does not 
appear to be any increase in the average number of large  foci at all timepoints although 
there is an increase in medium and large foci in P5 nuclei 30 minutes after 0.5 Gy 
compared to sham (average 10.48 foci in foci positive nuclei, of which, 3.09 were 
medium and 1.02 large after 0.5 Gy compared to 0.05 large foci in an average 2.54 
foci/nucleus) in shams.  This is also the case in ageing P10 cells after 0.3 Gy (1.2 
medium foci/nucleus), and 0.5 Gy (2.11 medium foci/nucleus) compared to sham (0.25 
foci).  It is possible to determine from figure 3.34  that there is an increase number of 
foci of larger size in the late passage nuclei compared to mid passage (figure 3.36) 
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which is shown by an increase in the fraction of foci being of medium and large (>0.5 
µm) size.  It is difficult to interpret whether there is a radiation-induced change in focus 
size over time, and whether or not there is an increase in focus size in later passage 
cells.  However, although there appears to be no distinct radiation-induced difference in 
foci size over time, there is an obvious increase in the average focus size in sham and 
irradiated P10 nuclei, and the fraction of 53BP1 foci that are of a medium and large 
size, is greater than seen in younger mid passage cells  In mid passage NHBE cells there 
is a visibly increased fraction of large foci (>1.0 µm and 100+  pixels in size) at 30 
minutes after exposure to 0.5 Gy, which is not shown by 24 hours whereby  
approximately 80% of foci scored are of a small size (<0.5 µm and ~6-50 pixels).  
However at 48 hours after exposure to 0.5 Gy, there is an increase in the number of 
large foci which is seen to be different from the exposed cells at 24 hours, and also 
different from both the 24 hour and 48 hour shams.  The difference between the 
composition of these large foci seen at early and later times would need to be 
investigated further by extending observation times.  The data thus far shows no 
evidence of a radiation-induced increase in foci size in NHBE cells up to 216 hours 
after irradiation.  In order to determine if there was any change in foci size or evidence 
of persisting foci that are different to shams beyond 216 hours, foci size was quantified 
up to 792 hours after 0.3 and 0.5 Gy exposure.  
 Due to the majority of damage being repaired in NHBE cells by 24 hours and therefore 
a high proportion of nuclei will contain zero foci, the average focus size will be 
discussed for foci positive cells only.  Table 3.7 and figure 3.37 and 3.38 shows the 
average number and size of 53BP1 foci in NHBE cells over a period of 33 days after IR.  
Based on average alone the average number of foci in foci positive nuclei remains fairly 
constant from 24 – 792 hours after sham (range = 1.6-2.1 foci/nucleus), 0.3 Gy (range 
=1.4-2.3 foci/ nucleus) and 0.5 Gy (range =1.7-2.3 foci/nucleus).  Of these foci, small 
foci (<0.5µm) account for ~80% (sham), 83% (0.3 Gy) and 81% (0.5 Gy) of the foci per 
foci positive nuclei.  Medium foci (0.5-1.0 µm) account for ~13% foci (sham), ~12% 
foci (0.3 Gy) and ~13% foci (0.5 Gy) which is consistent with an increasing proportion 
of medium foci seen in ageing late passage cells previously (~16%, ~15% and 16% in 
late passage sham, 0.3 and 0.5 Gy exposed NHBE respectively).  Interestingly, the 
proportion of large foci in sham nuclei increases from 2.12 % (24 hrs) to 8 % (792 hrs).  
The total proportion of large foci after 0.3 Gy exposure follows a similar trend to sham 
nuclei (3.23% at 24hrs and 5.35% at 792 hrs) suggesting that there is an age-associated 
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increase in the proportion of large foci during the culture period and not a radiation-
effect.  So although there is no radiation-induced increase in size or number, the 
proportion of large and medium foci in P7-P13 nuclei are consistently higher than in 
mid passage P5 nuclei again providing a baseline for the proportion of large and 
medium foci within ageing cultures 
 
Figure 3.37 AutoRIF analysis of average size and number of 53BP1 foci in foci positive 
NHBE nuclei only, up to 792 hours after 0.3 and 0.5 Gy.  Dashed lines represent average 
number of small (blue line; 1.56), medium (red line; 0.27) and large (green line; 0.1) 53BP1 foci 
in mid passage foci positive sham NHBE nuclei only.     
 
Figure 3.38 AutoRIF analysis of 53BP1 foci size in foci positive NHBE cells up to 792 
hours after 0.3 and 0.5 Gy exposure.  
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Figure 3.39 Average area of 53BP1 foci in mid (A) late (B) passage NHBE cells. C 
represents cells exposed at P7 and maintained in culture (area in pixels). 
0
10
20
30
40
50
60
0.5 24 48 0.5 24 48 0.5 24 48
Sham IR 0.3 Gy IR 0.5 Gy
A
v
er
a
g
e 
fo
cu
s 
a
re
a
 (
p
ix
el
s)
 
0
10
20
30
40
50
60
0.5 48 216 0.5 48 216 0.5 48 216
Sham IR 0.3 Gy IR 0.5 Gy
A
v
er
a
g
e 
fo
cu
s 
a
re
a
 (
p
ix
el
s)
 
0
10
20
30
40
50
60
2
4
4
8
1
9
6
3
8
4
5
2
8
6
2
4
6
9
6
7
9
2
2
4
4
8
1
9
6
3
8
4
5
2
8
6
2
4
6
7
2
7
9
2
2
4
4
8
1
9
6
3
6
0
4
8
0
6
4
8
Sham IR 0.3 Gy IR 0.5 Gy
A
v
er
a
g
e 
fo
cu
s 
a
re
a
 (
p
ix
el
s)
 
Time after IR (hr) 
B 
A 
C 
96 
 
4 Discussion 
The rationale of this study is based on the recent suggestion that exposure to 
ionising radiation (IR) may initiate a stress-induced premature cellular senescence 
(SIPS) in cells with intact signalling pathways (Ben-Porath, Weinberg 2005, 
Suzuki et al. 2001, Suzuki, Boothman 2008, Rave-Fränk et al. 2001) .  The 
overall aim was to examine the effect of moderate to low dose exposures of IR on 
DNA damage induction and persistence, and the effect, if any, that this may have 
on the proliferative status of primary normal human bronchial epithelial (NHBE) 
cells.  To do this, we irradiated sub-confluent NHBE cells with gamma IR and 
fixed at varying times for immunofluorescent staining.  Specifically, these cells 
were then fixed and stained for indirect immunofluorecence for detection of the 
Ki-67 protein, which is a proliferation marker exclusively linked with the active 
phases of the cell cycle (Bridger, Kill & Lichter 1998, Gerdes et al. 1984) and for 
the DNA damage protein 53BP1, which is recruited to DSB sites and like 
phosphorylated histone H2AX (γ-H2AX), is a useful marker of DSB damage.  
Both Ki-67 and 53BP1 were analysed over time to determine if, after a single 
acute dose, we saw any radiation-modifying effects that may suggest the induction 
of a stress–induced premature senescence phenotype.     
NHBE cells were used in this study as they represent a clinically relevant target 
cell for studying low dose ionising radiation effects, including those received 
during diagnostic procedures (i.e. CT scans and chest X-rays), the usage of which 
are increasing.  In addition NHBE cells have been shown to act as immune 
effector cells (Nakamura et al. 1991, Kaufman et al. 2001) meaning they are a 
useful cell type for studying possible inflammatory responses as a result of IR and 
stress-induced premature senescence (SIPS).  Furthermore, NHBE cells are 
reported to be more resistant to the DNA-damaging effects of IR compared to 
lung fibroblasts, and have shorter G1 and G2 cell cycle delay responses potentially 
as a result of higher basal levels of p53 (Gadbois, Lehnert 1997).  Given that lung 
epithelial cells are almost continuously exposed to DNA-damaging agents, a 
limited checkpoint response in these epithelial cells may increase the chance of 
unrepaired lesions being transmitted to future progeny.       
97 
 
In this study, NHBE cells grew exponentially in culture to ~80% confluency at 
each passage, being classified as early, mid or late passage depending on their 
time to reach confluency, morphological appearance and passage age. For 
example, NHBE cells grown beyond passage 10 were categorised as late passage 
cells due to an observed reduction in cell counts at each passage, increased time to 
reach confluency and reduced cell viability.  The total culture period of our NHBE 
cells represented between 9-18 population doublings (PDs) with Lonza 
guaranteeing the viability of D2 and D3 NHBE cells to approximately 18 and 15 
PDs respectively.  After this, a higher rate of cell death is observed, encompassing 
reduced viability, change of cell morphology and altered gene expression.  This 
suggests that extended culture will result in the classical changes seen with cells 
becoming senescent and this is consistent with our calculations of mid and late 
passage cells and the growth and morphological observations we made of the cells 
in culture.  Cumulative cell growth curves (figure 3.3) for  0.3 Gy and 0.5 Gy 
irradiated NHBE cultures showed no clear difference in growth rates to those seen 
in sham irradiated cells during the observed culture period, suggesting that there is 
no radiation effect on growth rates after a single acute dose.    
In order to determine the proliferative status of our NHBE cells after exposure to 
IR, we employed an immune-fluorescent co-stain method whereby cells were 
stained against both Ki-67 and 53BP1.  The nuclear antigen Ki-67 is associated 
with cellular proliferation but even 30 years after its discovery by Gerdes and 
colleagues (1983), its exact function still remains unknown (Endl, Gerdes 2000, 
Starborg et al. 1996, Gerdes et al. 1983).  They showed expression of a nuclear 
antigen that was only found to be associated with proliferating cells and thus the 
active phases of the cell cycle, but which was absent in non-proliferating, 
quiescent and senescent cells (Gerdes et al. 1984, Gerdes et al. 1983).  Schluter 
(1993) also showed that pKi-67 was necessary for cell cycle progression by 
incubating IM-9 cells with synthetic antisense deoxyoligonucleotides 
complementary to the translation start site of pKi-67 (Schlüter et al. 1993).  This 
removal of pKi-67 resulted in the prevention of [
3
H] thymidine-incorporation and 
the prevention of cellular proliferation. In addition to this, the confined nuclear 
distribution of Ki-67 is cell cycle dependant and is associated with the nucleoli of 
proliferating cells where it stains regions surrounding the fibrillar centres, 
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suggesting that Ki-67 plays a role in regulation of nucleolar metabolism and the 
rate of ribosome synthesis (Kill 1996, Gerdes et al. 1983, Schlüter et al. 1993, 
Verheijen et al. 1989) .  However, as Ki-67 negative cells are still viable, it 
suggests that pKi-67 is not specifically needed for nucleolar function but is 
important for structural maintenance at different stages of the cell cycle.  
Moreover, Ki-67 positive staining patterns can differentiate cells into different 
phases of the cell cycle.  For instance, cells displaying small, numerous foci 
throughout the nucleoplasm, are classified as type I distribution, corresponding to 
G1 (Bridger, Kill & Lichter 1998, Kill 1996).  Ki-67 staining is associated with the 
dense fibrillar components of reforming nucleoli and restricted to the nucleoli in 
type II distribution, which encompasses late G1, S phase and G2 cells where 
localisation is maintained in this manner until the middle of G2 phase (Kill 1996). 
We therefore exploited these features of Ki-67 staining to enable us to distinguish 
between proliferating and non-proliferating cells within the NHBE population.   
 We found ~25% of mid passage NHBE cells (~passage 5-6) were Ki-67 negative 
(range 16-36%) compared to 57% Ki-67 negative (range 43-62%) in later passage 
cells (figure 3.25 and 3.26).  This showed a clear increase in the non-proliferating 
fraction of NHBE cells, thought to be senescent, with increasing cellular passage.  
Irrespective of passage age,  ~83% of the Ki-67 positive fraction (range 76-97%, 
data not shown) were of type II staining distribution, representative of being in 
late G1, S, G2 (Bridger, Kill & Lichter 1998), and exposure to 0.3 and 0.5 Gy did 
not appear to modify this relative to sham during the initial observed period of up 
to 216 hours.  Similarly, 44% of passage 7 1HD (data not shown) cells were Ki-67 
positive and 86% of this fraction exhibited a type II staining distribution, while 
Kill (1996) showed that 84% of human dermal fibroblasts (HDFs) stained with a 
type II distribution (Kill 1996).  Thus a similar proportion of our non-
synchronised NHBE cells are in late G1 onwards at all times analysed.  It is 
expected that the fraction of Ki-67 positive cells will decrease with passage as 
shown by Kill (1996) and Thomas (1997) (Kill 1996, Thomas et al. 1997) which 
is representative of an increasing number of the cells reaching their maximum 
replicative age and becoming senescent.  The NHBE cells used in this study are 
grown in serum-defined BEBM (section 2.2.3.1) and therefore are under 
conditions whereby Ki-67 negative staining is representative of the senescent 
fraction of a culture, in contrast to quiescent cells (also Ki-67 negative) (Kill 
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1996).  In concordance with mid and late passage Ki-67 fractions observed in 
NHBE cells, 39% (sham), 33% (0.3 Gy) and 39% (0.5 Gy) of NHBE cells at P7 
were Ki-67 negative suggesting a steady increase in the non-proliferative fraction 
with passage age.  However in contrast to this, when we continued subculture of 
NHBE beyond approximately 360-384 hours up to 792 hours we did not observe a 
linear expected increase in Ki-67 negative fraction (table 3.9).  Instead we 
observed that the fraction of Ki-67 negative cells remained constant or reduced in 
both sham and irradiated samples approximately 15-20 days into the long-term 
culture (figure 3.28).  A possible explanation for this 
 is given later in this Discussion.  
 The application of Ki-67 analysis for determination of senescent cells was 
corroborated by parallel staining for senescence-associated beta-galactosidase 
(SA-β gal) activity at pH 6.  Cells irradiated at Passage 7 and grown for a total of 
33 days were also stained for SA-β gal to determine if there was any evidence of 
premature-radiation-induced senescence comparative to shams.  We showed that 
the SA-β gal positive fraction of NHBE increased from 11% at passage 4 to 21 % 
by passage 7 representing an increasing number of cells that were senescing in 
culture.  Similarly, SA-β gal staining of P8-P13 NHBE cells showed a correlating 
trend in both sham and irradiated samples (figure 3.6) however similar to that 
observed with Ki-67, we did not see the expected increase in cells IR at P7 and 
cultured beyond P10-P11 (figure 3.6).   Although the percentage of SA-β gal 
positive cells subsequently dropped after P10-P11, this increase was seen in 
culture for a longer period than was seen by Ki-67 analysis of cells of the same 
passage age (P9 onwards).   It must always be noted that the accuracy of using β-
galactosidase activity to detect the presence of senescent cells in vitro and in vivo 
has long been debated.  For instance, SA-β gal activity at pH 6.0 has also been 
shown in adult melanocytes (Dimri 1995), as well as in quiescent serum-starved 
or heparin-treated murine fibroblast cells, leukemic cells that have undergone 
differentiation, or in cells held at confluence (Yegorov et al. 1998, Severino et al. 
2000, Krishna et al. 1999).  As a result of the variation that is seen across sample 
dishes often as a result of user subjectivity and non-specificity of the assay under 
different culture conditions, the detection of senescent/non-proliferating cells 
should not be determined by SA-β gal activity alone, and should always be used 
in conjunction with other detection methods.  For both SA-β gal activity and Ki-
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67 staining the reproducibility of analysis was excellent in this study meaning 
such technical considerations may not account for the observation that the 
percentage of SA-β gal positive nuclei and Ki-67 negative at P13 decreased 
compared to earlier cultures.  Instead this may suggest that a fraction of senescent 
cells are being lost at each passage such that we are not identifying a true 
accumulation of senescent cells.  This highlights a possible issue with studies 
designed to observe the late effects after IR exposure, where the long-term 
maintenance of NHBE cells by continued subculture may impact on the growth 
characteristics of these primary cells past P10 or by the continual loss of senescent 
cells due to technical reasons.  In addition, although the BEBM medium contains 
supplements to ensure that the NHBE cells do not become differentiated during 
subculture, we cannot exclude this as a possibility since no markers to distinguish 
between cells that have become terminally differentiated were used.  Overall 
though, we measured an age-associated increase in SA-β gal staining however we 
did not observe any enhancement of this after exposure to a single acute dose of 
0.3 and 0.5 Gy.    
IR-induced 53BP1 foci have been shown to form within minutes peaking around 
30 minutes post-irradiation, in a dose-dependent manner (Anderson, Henderson & 
Adachi 2001).  Our findings correlate with the literature, showing the induction of 
53BP1 foci in mid-passage NHBE cells 30 minutes after exposure to both 0.3 Gy 
(average 5.3 foci/nucleus) and 0.5 Gy (6.5 foci/nucleus) to be elevated compared 
to sham (1.16 foci/nucleus) (figure 3.8).  In late-passage cells exposed under the 
same conditions, 53BP1 foci were induced to the same efficiency as in mid-
passage cells after exposure to 0.3 Gy (6.86 foci/nucleus) and 0.5 Gy (8.21 
foci/nucleus) compared to sham (2.44 foci/nucleus) (figure 3.11).  However 
average foci numbers were higher due to the increased background of foci that is 
seen in ageing NHBE cells.  An increase in background DNA damage foci in 
ageing cultures is also well documented in other cell types, specifically early 
passage fibroblast cultures showed 0.2-0.3 γ-H2AX foci/cell increasing to 2.2-4.1 
foci/cell in senescent cultures (Sedelnikova 2004), with senescing human and 
mice cells in other studies also showing an increasing accumulation of foci (Paull 
et al. 2000, Sedelnikova 2004, Rothkamm, Löbrich 2003, Sedelnikova et al. 
2002).  This increasing trend was further seen by the distribution of foci in NHBE 
cells of differing passage age, with only 23% of late passage (P10) sham nuclei 
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containing zero foci (range 15-34%), compared to ~50% in mid passage (P5/6) 
cultures (range 38-55%) (figure 3.9 and 3.12).  Interestingly for all cultures in the 
extended population (figure 3.13), a decline in the average number of foci and an 
increase in nuclei that had zero foci was observed at later times, suggesting that 
cells are lost from continued culture (beyond P9 in this study).  We saw a high 
background of 53BP1 foci in P10 sham nuclei however we did not see this in the 
P10 nuclei of cells that had been sham irradiated at P7 and maintained in culture.  
Therefore it would be advisable to observe whether the average background level 
of foci would decline and would suggest that the cells are being removed from the 
population during long-term culture as a result of apoptosis or an aspect of the 
technical design. 
The recruitment of foci to the sites of DSBs and repair of damage is thought to be 
equivalent at high and low doses of IR (Asaithamby, Chen 2009) however groups 
have also shown that foci are not resolved after exposure to very low doses of 
ionising radiation (<10mGy) (Grudzenski et al. 2010).  53BP1 and γ-H2AX foci 
numbers rapidly decrease in the time after challenge due to an elimination of the 
cells that carry unrepaired DSBs, either by induction of apoptosis as a 
consequence of un-repairable damage, or through the sufficient implementation of 
cellular repair mechanisms (Rothkamm, Löbrich 2003).  Although still 
controversial, the rate that 53BP1 foci are resolved show similar kinetics to DSB 
repair and therefore their disappearance is thought to correlate with DNA repair 
(Rappold et al. 2001, Schultz et al. 2000a).  Such a decline in foci number was 
seen in both mid and late passage NHBE cells 48 hours after IR, whereby foci 
numbers had returned to sham levels (figure 3.8 and 3.11).   Interestingly though, 
manual analysis determined that 216 hours after exposure to 0.5 Gy, the average 
foci number (4.73 foci/nucleus) remained elevated compared to sham  (3.31 
foci/nucleus, P=<0.0001) which was also accompanied by a broader distribution 
of damage foci compared to sham in late passage NHBE cells.  However, 
AutoRIF analysis of a higher number of nuclei highlighted that there is a broader 
distribution of 53BP1 foci in late passage NHBE cells up to 48 hours after 0.3 and 
0.5 Gy, and relative to sham by 216 hours.  The slight variation seen in the 
distribution of DNA damage foci after IR by different analysis methods highlights 
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the potential effect that individual nuclei variation will have on small sample 
sizes.   
 There is also evidence to support the hypothesis that persisting foci are of 
increased size at extended times after exposure to IR (McVean et al. 2012, Suzuki 
et al. 2006, Suzuki et al. 2012, Leatherbarrow et al. 2006, Staaf et al. 2012).  We 
also observed this during manual observation in this study whereby IR induced 
foci (RIF) at later times were larger and more intensely stained than the small 
endogenous foci seen in un-irradiated cycling cell nuclei (Ichijima et al. 2005).  
To quantify these larger foci at extended times after IR we employed AutoRIF 
(McVean et al. 2012) to quantify foci of categorised sizes in both mid and late 
passage cells.  Foci were classified as small (<0.5µm), medium (0.5 – 1.0µm) and 
large (>1.0µm).  Specifically, our results showed that there was a distinction 
between the proportion of medium and large foci in mid and late passage cells 
(figure 3.33 and 3.35).  In addition, NHBE cells irradiated at P7 and cultured 
continuously for up to 33 days after exposure also contained a higher proportion 
of medium and large foci compared to NHBE cells that were IR and fixed at mid 
passage.  Specifically the proportion of medium foci scored in sham NHBE nuclei 
appears to be higher in later passage nuclei (16%) compared to mid passage nuclei 
(10%), with a further increase in the proportion of large foci seen in P7-P13 nuclei 
(range=2% at 24 hours and 8% large by 792 hours) (figure 3.37) suggesting that 
there is indeed an age-related increase of persistent foci size in NHBE cells of 
increasing passage, allowing distinction between young and ageing NHBE cells in 
culture.  However, no difference in the size of 53BP1 foci was observed relative 
to sham (figure 3.34, 3.36 and 3.38).  Therefore of the doses and dose regimes 
studied so far, we found no evidence of a radiation-induced increase in foci size 
over a period of 33 days which suggests that a single acute dose of 0.3 Gy or 0.5 
Gy is not sufficient to induce any radiation effects above that of baseline changes 
in the ageing culture, in NHBE cells.   
Given the relationship between persisting foci and the trend that they are of a 
relative increased size in ageing cell populations and also, that the fraction of Ki-
67 negative and SA β-gal positive cells increase with replicative age, we were 
interested in whether there was any evidence of persisting foci predominantly 
occurring in Ki-67 negative cells.  We saw no difference in the efficiency of 
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induction of 53BP1 foci and no increased sensitivity to damage in either Ki-67 
positive (proliferating) or Ki-67 negative (senescent) mid passage NHBE cells at 
30mins (figure 3.29).  This was also shown in 1HD cells whereby we saw no 
difference in the average number of foci in either Ki-67 positive or negative cells 
(data not shown) within 30mins of IR.  However there does appear to be a 
difference in how the damage is processed between proliferating and senescent 
cells in late passage cells (figure 3.30 and 3.31).  Although the co-stain graphs are 
difficult to interpret due to the spread of foci number, the number of Ki-67 
negative nuclei with >6 foci appears to be altered relative to sham (5.9%), 216 
hours after exposure to 0.3 Gy (11%) and 0.5 Gy (19%).  This may suggest that at 
extended times after exposure, there may be increasing numbers of NHBE cells 
with an increased foci number relative to sham in Ki-67 negative cells as you 
might predict. However similar to our previous findings, we did not observe any 
influence of a single acute dose of 0.3 or 0.5 Gy up to 792 hours after irradiation.  
As discussed previously, the discrepancies in the Ki-67 fraction of cells observed 
at later times suggests that there may have been a loss of Ki-67 negative cells 
which may or may not have contained elevated foci (of increased size) as a result 
of the effect of long-term culture of these primary cells.  Senescent cells are 
thought to be more adherent to flasks than exponentially growing cells, and this 
may mean that during  continued subculture, a fraction of these senescent cells are 
left behind at each passage and as a result do not contribute to the new fraction 
that may have become senescent by the next observation period.  This may 
explain why the Ki-67 negative fractions of NHBE did not increase with 
subsequent passage and with the age of culture as expected.  Previous analysis of 
the fraction of Ki-67 negative mid passage cells showed good correlation with the 
fraction of SA-β gal positive cells in cultures of similar age, allowing the 
conclusion that these 2 markers are indeed identifying the same proportion of cells 
within culture.  It is expected, according to Kill, Thomas (Kill 1996, Thomas et al. 
1997) and previous work, that the relationship between Ki-67 negative cells and 
SA-β gal positive cells should be relatively inversely proportional.  Co-staining 
nuclei with Ki-67 and the fluorogenic substrate for β-galactosidase known as 5-
dodecanoylaminofluorescin di-β-D-galactopyranoside (C12FDG) (Debacq-
Chainiaux et al. 2009) would allow identification of both proliferative status and 
quantification of SA-β gal activity within each cell.  Further parallel staining of 
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these CD12FDG stained nuclei for 53BP1 foci would provide a good model to 
directly distinguish between SA-β gal positive cells (Ki-67 negative) with foci.   
Future recommendations for AutoRIF analysis over extended periods of time after 
moderate to low doses of radiation, must take into account the high background 
that is seen in both sham and irradiated ageing nuclei.  After 24 hours when repair 
is thought to have been completed the background intensity is at risk of being 
over-enhanced during image capture resulting in a false increase in the number of 
small foci detected by AutoRIF which are actually characterised as ‘salt and 
pepper’. The software however allows a huge number of nuclei to be imaged and 
analysed and shows generally good correlation with smaller manual analyses.  An 
awareness of the advantages and caveats of the system that have been discussed 
throughout will allow the user to ensure that the optimal settings are used 
according to experimental design to determine both foci number and size.  Further 
modifications that could be made during analysis of AutoRIF output, would be to 
modify excel formulas to disregard nuclei with high number of foci in and 
therefore apply a maximum cut-off for foci number also.  This would allow 
exclusion of those nuclei with high numbers of small endogenous foci that may be 
as a result of S phase or dividing cells, as were excluded by manual analysis.  ,It is 
therefore necessary that steps are taken to ensure that this small population of 
cells are either excluded from the population or they are identified and accounted 
for.  As it is not possible to synchronise the growth of NHBE cells, the use of 
PCNA antibodies would be of great benefit here to estimate the fraction of S 
phase cells.  Additionally, the development of antibodies that are aimed against 
irreparable IRIF would potentially alleviate the impact that ambiguous foci have 
on the data.  Future analysis should also be less focussed on the presence of foci 
that are less than 0.5µm in size, and capture settings adjusted to focus on medium 
and large foci which are of greater importance in this project at later times after 
IR.  
In conclusion, senescence and ageing have been inexplicably linked in a number 
of pathologies, including cancer possibly as a result of genomic instability and 
low fidelity repair of DNA damage.  A direct link between in vivo and cellular 
ageing and senescence has not yet been conclusively determined although the 
recent work by Baker and colleagues (2011) provided evidence of a direct link 
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between senescent cells and age-related pathologies in mice (Baker et al. 2011).  
Of particular importance in this project was whether NHBE cells underwent 
stress-induced premature senescence in response to single acute doses of IR and if 
so, future considerations should focus on whether such responses may modify the 
effects of low dose exposures.  In particular the impact of persisting inflammatory 
or DNA damage responses, either by release of inflammatory products from 
NHBE cells themselves, or as a result of senescent cells being associated with a 
secretory phenotype.  
Although our current data has shown that a single acute dose of either 0.3 or 0.5 
Gy Cobalt
60
 γ-rays does not result in any obvious modifying effects above the 
levels seen in sham NHBE cells of mid and late passage, the endpoints that were 
analysed have shown a clear distinction between  mid and late passage cells.  This 
provides an excellent model for comparing young and older NHBE cells, which 
could be applied to study more elaborate radiation strategies.  It has well 
documented that senescence has been induced after exposure to both high (Suzuki 
et al. 2001) and chronic low doses (Tsai et al. 2005, Tsai et al. 2009) of radiation 
and although exposure to a single acute moderate dose of 0.3 and 0.5 Gy has 
shown no effect relative to sham, it is essential that the impact of chronic low and 
fractionated dose exposures are investigated in this cell type. 
In order to further investigate the effect of low dose exposures on the initiation of 
a stress-induced senescence phenotype in NHBE cells, extended observation of 
these cells in culture would need to be optimised to ensure that senescent cells 
within the culture are maintained, or the fate of cells with increased foci are 
determined.  Alongside detailed analysis of the endpoints discussed in this project, 
molecular assays to assess changes in gene (qtPCR) and protein expression 
(western blots and ELISA) should form a key element to future analysis of the late 
effects of ionising radiation. Sampling of NHBE medium for the detection of 
inflammatory cytokines/chemokines such as IL-8 and IL-6, which are known to 
be secreted by NHBE epithelial cells after damage, and ICAM-1 expression which 
is found to be up-regulated on NHBE epithelial cell membranes (Martin et al. 
1997) would also allow us to determine if there are any radiation-induced 
responses over time.  
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Further optimisation of an air-liquid interface 3D (ALI) model would allow 
differentiation of NHBE cells into a pseudostratified epithelial layer containing 
basal epithelial cells,  mucus producing goblet and ciliated columnar cells, which 
is more representative of an in vivo tissue model.  This tissue model is also 
commercially available from MatTek and has successfully been used by other 
groups to study radiation effects (Sedelnikova et al. 2007).  Exploration of 
culturing these 3D tissue models with (matched) fibroblasts, or immune cells 
would also allow us to determine the importance of the stromal matrix and 
immune cell interaction after radiation exposure. 
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